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The Osterix Reporter Mouse Identifies a Bone Marrow Skeletal Progenitor Cell Population 
Sara Elaine Strecker, Ph.D. 
University of Connecticut, 2013 
 
Multipotent skeletal progenitor cells that reside in the bone marrow and contribute to the 
maintenance and repair of bone tissue are difficult to identify and, as a result, remain poorly 
understood.  Osterix is a zinc finger transcription factor, which functions as a key regulator of 
bone formation.  Cells of the osteoblast lineage generate bone tissue by depositing a mineralized 
matrix [1, 2].  Osterix is selectively expressed in cells of the osteoblast lineage and has an 
essential function in osteoblast commitment and bone formation [1, 3].  While it is generally 
accepted that Osterix is expressed in early osteogenic precursors [3, 5-7], recent studies from our 
lab and others have suggested that Osterix may be expressed at an even earlier stage of the 
lineage, being present in a multipotent bone marrow skeletal progenitor cell population, which 
can be expanded in vitro as a bone marrow mesenchymal stem cells (BMSCs). 
To further explore the expression of Osterix in early bone marrow skeletal progenitor 
cells, we have generated Osterix-Cherry reporter mice. Preliminary characterization of this 
animal model suggests reporter expression accurately represents endogenous Osterix expression, 
being largely restricted to skeletal tissues. Additionally, FACS isolation, replating, and 
differentiation of Osterix-Cherry+ bone marrow derived stromal cells provide evidence of their 
skeletal multipotency, indicated by their ability to differentiate into osteoblasts, adipocytes and 
chondrocytes.  Based on our preliminary data, we have formulated the following hypothesis: 
Osterix expression identifies a multipotent bone marrow skeletal progenitor cell population. 
The goals of my thesis will be to: (1) characterize Osterix reporter expression during 
skeletal development and (2) characterize the bone marrow cell population expressing the Osterix 
reporter gene.    
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CHAPTER I: INTRODUCTION 
THE REGENERATIVE CAPACITY OF BONE TISSUE 
 
An increasing body of work provides evidence for the complex role of bone tissue 
in a variety of physiological processes.   Mechanically, the skeleton provides structural 
support, protects delicate internal organs, allows for motion and movement, and even 
allows for sound conduction in the inner ear.   Metabolically, bone tissue is a critical 
regulator of mineral homeostasis in that it is the primary site of calcium and phosphate 
storage which is regulated  in conjunction with bone resorption and new bone deposition 
[6, 8-14].     
Bone tissue 
also has an amazing 
capacity to 
regenerate, whether 
it involves the 
mechanisms of 
normal bone turnover 
or injury induced 
repair.  Bone 
remodeling occurs 
throughout life.  In this 
process, mature bone 
FIGURE 1 : SCHEMATIC OF BONE FORMATION AND 
RESORPTION   
The mesenchymal stem cell gives rise to osteoblast precursors which differentiate into 
osteoblasts, the bone forming cells of the skeletal system. The hematopoietic stem cell gives rise 
to the osteoclast, which resorbs bone.  [4]   
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tissue is resorbed and new bone tissue is laid down in the same place. The balance 
between these processes controls for the reshaping of the skeleton and allows for the 
repair of tissues following injury, such as overt fracture, but also in response to the 
micro-damage that occurs during normal activity.  Remodeling the skeleton also allows 
for it to respond to mechanical loading. In the adult, approximately 10% of the skeleton is 
remodeled per year [14].  
In this regard, it is generally accepted that mesenchymal stem cells provide an 
essential cellular source from which mature bone cells differentiate to support these 
regenerative processes (Fig 1) [15, 16].  However, our knowledge of mesenchymal stem 
cells or skeletal progenitor cells remains poorly understood.  The focus of my thesis work 
has been on increasing our understanding of bone marrow skeletal progenitor cells. 
THE DISCOVERY OF BONE MARROW SKELETAL PROGENITORS 
 
Bone marrow stromal cells (BMSCs)  were first discovered by Friedenstein in 
1966 [17] and further characterized by his group as a rare cell population within the bone 
marrow that maintained skeletal potential [18].   Because of their skeletal potential and 
their accessibility through bone marrow aspiration, the application of BMSCs for 
therapeutic purposes has been the driving motivation to understand their biological 
properties. However, because of their rarity within the bone marrow, multipotent skeletal 
progenitors have remained a challenge to study in vivo and much of our understanding 
has been ascertained after expansion in vitro.  In this regard, BMSCs display selective 
adherence to tissue culture plastic relative to most other hematopoietic cell types, retain 
the capacity to self-renew, support hematopoiesis, and differentiate into a variety of 
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connective tissue cell types, including the osteoblast, chondrocyte, and adipocyte[15, 19, 
20] and are considered to be  derived from a non-hematopoietic cellular component of the 
bone marrow stroma [21].  
 
WHAT ARE STROMAL CELLS? (CURRENT THINKING) 
 
BMSCs are a subpopulation of cells within the marrow and are considered to be a 
non-hematopoietic cellular component of the bone marrow stroma, with recent studies 
suggesting that the BMSC may represent a subpopulation of reticular cells [21, 22]. More 
recent studies have alluded to the potential identity and function of reticular cells within 
the bone marrow.  Reticular cells are a heterogeneous perivascular cell population located 
adjacent to endothelial lined sinusoids within the bone marrow [23].  Reticular cells 
function to support different hematopoietic events, including hematopoietic stem cell 
retention and self-renewal and B-cell development [24, 25].  Selective isolation and 
characterization of CD146+ bone marrow reticular cells from human tissue has also 
revealed their BMSC-like properties [26, 27].  While mouse BMSCs do not express 
CD146, Cxcl12+ and Nestin+ murine bone marrow perivascular cells also display 
BMSC-like properties.  Interestingly, human CD146+ reticular cells and murine Cxcl12+ 
and Nestin+ cells retain similar gene markers including Cxcl12, Stem Cell Factor (SCF), 
and Angiopoietin 1. Surprisingly, these cells have also been shown to express Osterix [24, 
27-29], which was previously considered to be a skeletally specific transcription factor.    
Traditionally, the identity of various cell types within the bone marrow has been 
characterized based on cell surface profiling. Cells which express CD45 or leukocyte 
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common antigen, are considered to be of the hematopoietic lineage[30], cells which 
express CD11b are of the myeloid lineage [31], and cells which express CD31 are of the 
endothelial lineage [32]. The exclusion of cells which are positive for any of these three 
lineage markers has been used to narrow down the various cell populations within the 
marrow, while other markers are being sought that will define the BMSC. In mice, three 
specific markers have been shown to be expressed on the cell surface of putative BMSCs; 
these markers include Sca-1 [33], CD44 and CD29 [34]. Multiple other markers are 
currently being examined to try to find the one cell surface marker that defines a BMSC, 
as seen in the human mesenchymal stem cell / reticular cell which is positive for CD146, 
without luck.   
ANATOMICAL ORGANIZATION OF THE BONE MARROW ENVIRONMENT 
 
The organization of the bone marrow is a crucial clue to furthering our 
understanding of the various cell types which reside in this heterogeneous environment.  
The bone marrow is, indisputably, a complicated environment, consisting of many cell 
types and it is very difficult to accurately and consistently delineate different cell types 
within the stroma.  The bone marrow itself largely consists of hematopoietic cells.  With 
this in mind, one might think the marrow environment is largely fluid, but that is not the 
case.  Fate mapping studies have shown that cells within the stroma do not move 
throughout the compartment [35, 36], but they maintain a fixed position from embryonic 
establishment throughout adult life [36].   
Recent studies by Ding et al, have shown that different types of progenitor cells 
occupy physically distinct niches within the bone marrow stroma.  Hematopoietic stem 
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cells (HSCs) occupy a perivascular niche whereas early lymphoid progenitors occupy an 
endosteal niche [35]. This provides more evidence that the marrow is a highly organized 
compartment, with a variety of cellular signals yet to be determined which are promoting 
and maintaining different phenotypes in a variety of cells that are in close proximity to 
each other.  In this thesis the focus will be on osteoblasts and BMSCs which contribute to 
the osteoblastic lineage only, as the identity of other cells within the marrow is still being 
defined.  
THE ORIGIN OF BONE MARROW SKELETAL STEM CELLS 
 
ENDOCHONDRAL OSSIFICATION AND THE BONE MARROW COMPARTMENT 
 
 During embryonic development, bone tissue forms through two distinct processes 
termed:  intramembranous ossification and endochondral ossification.   Most craniofacial 
bones develop through intramembranous ossification where mesenchymal cells directly 
differentiate into osteoblasts and osteocytes [10].  Mesenchymal condensations are 
formed at the site of future bone development where the mesenchymal cells become 
osteoblasts and produce bone matrix directly.  The cells which become the craniofacial 
skeleton are predominately derived from the cranial neural crest[37].   The axial and 
appendicular skeleton develop through endochondral ossification, where mesenchymal 
cells first condense and differentiate into chondrocytes to form a cartilaginous anlagen 
[6]. These skeletal cells originate from the mesoderm[37]. This cartilaginous anlagen 
serves as a template for bone formation as chondrocytes within the anlagen signal to the 
outer perichondrium providing critical signaling cues that coordinate the growth and 
differentiation of cartilage with bone [6]. There is generally very little marrow space in 
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bones which form through intramembranous ossification, whereas bones which form 
through endochondral ossification have a large marrow compartment. [38].   
 
FORMATION OF THE STROMA 
 
Formation of the stroma occurs during chondrocyte maturation and is coordinated 
with osteoblast differentiation.  In the beginning of this process, signals secreted from 
hypertrophic chondrocytes trigger vascular invasion. During embryonic endochondral 
bone formation, factors secreted from the maturing growth plate chondrocytes initiate the 
expression of Runx2 in the adjacent perichondrium. Runx2 is a transcription factor that is 
considered to be at least one of the two master regulators of osteoblast differentiation.   
Mice deficient for Runx2 completely lack bone tissue and gene markers of osteoblast 
differentiation.  Runx2 also turns on Osterix, another key transcription factor essential for 
osteoblast differentiation.  Interestingly, Osterix knockout animals express normal levels 
of Runx2, however osteoblast differentiation remains impaired and no bone tissue forms. 
Fate mapping studies have also provided evidence that perichondrial cells also 
migrate into the developing bone marrow compartment during this time. Embryonic cells 
which have been marked by Osterix fate mapping studies have been shown to populate 
the bone marrow and differentiate into osteoblasts and osteocytes.   The precursors which 
form endochondral bone have been shown to come from a perichondrial origin.  These 
cells migrate into the bone marrow and subsequently contribute to the bone marrow 
stroma [36, 39].  
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Previous studies have also indicated a role for Osterix in the osteoblast  lineage, 
specifically in defining osteoblast commitment, but fate mapping studies have indicated 
the Osterix fate mapped embryonic precursors were not restricted to the osteoblastic 
lineage and instead contributed to many cell types within the bone marrow stroma. These 
cells included perivascular stromal cells, vascular smooth muscle, bone marrow 
adipocytes and perineural cells [36], indicative of the multipotency of this population. 
After vascular invasion occurs, much of the outer cartilage is replaced by bone as blood 
vessels further invade the epiphyses to form secondary ossification centers [40].  
OSTERIX 
 
Because of the important role of Osterix in early skeletal development, it merited 
further study. Osterix is a Cys2-His2 type DNA binding zinc finger protein belonging to 
the SP1 family of transcription factors. The protein itself contains three C2H2 zinc 
fingers along with a nuclear localization signal, enriching the location of Osterix to the 
nucleus.   The mouse Osterix gene is found on Chromosome 15. The human homolog of 
the mouse Osterix gene maps to 12q13.13. This is a three exon gene that encodes two 
distinct spliceaforms.  In humans, the first isoform is a 431 amino acid residue long 
protein isoform and the second is an amino-terminus truncated short protein isoform.  
Both isoforms are highly specific for osteoblasts, but some expression is seen in 
chondrocytes as well [41, 42].  
 In Osterix global knockout mice, the initial establishment of a cartilaginous 
skeletal template appears grossly normal, but osteoblast differentiation fails to occur, 
leading to perinatal lethality [1]. More recently, conditional knockout studies have shown 
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that Osterix is not only required for embryonic bone formation, but also for the 
maintenance of adult bone. Temporal inactivation of Osterix in postnatal and adult mice 
using an inducible ubiquitous Cre results in the absence of osteoblasts on the bone 
surface, severely altered bone structures, few mature osteoblasts and no Osteoid, leading 
to substantially weaker bones [3]. Interestingly, the chondrocyte specific disruption of 
Osterix, using a Col2a1-Cre, is also perinatal lethal.  The in vivo patterning of 
endochondral bone was impaired and delayed, with expanded hypertrophic zones and 
significant reductions in chondrocyte specific gene markers in this model [43]. Taken 
together these studies indicate that Osterix not only has a role in osteoblast differentiation 
and maintenance, but is also necessary for chondrocyte differentiation [44]. 
USE OF FLUORESCENT REPORTER MICE TO STUDY SKELETAL 
PROGENITOR CELLS 
 
In this thesis, we have used fluorescent proteins to help us study skeletal 
progenitor cells.  Fluorescent proteins were first isolated from the jellyfish and cloned in 
1992. They have since been modified to have different spectral characteristics. By 2009, 
over 15,000 papers have used Green Fluorescent Proteins (GFPs) or their derivatives in 
some form, and GFPs have been inserted into almost all laboratory species [45]. 
Fluorescent proteins make it much easier to track specific cells / cell types. As skeletal 
development is such a complex process, the use of fluorescent proteins allows for the 
tracing of various cells as development progresses.    
In order to make the most use of fluorescent proteins we have used Bacterial 
Artificial Chromosomes (BACs). BACs are vectors which hold large quantities (100-
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300kb) of DNA. These BACs often contain entire gene sequences as well as upstream 
regulatory elements.  The use of BAC transgenesis to create fluorescent reporter mice 
involves homologous recombination and the insertion of a plasmid containing the GFP 
color of interest[46].  By inserting a red GFP (Cherry) upstream of the translational start 
site on the BAC clone and subsequent pronuclear injection, we have created a real-time 
reporter mouse where Osterix expression is marked by a Cherry GFP.  By using these 
tools, we can compare the expression pattern of the reporter to that of endogenous 
Osterix as well as cross these Osterix-Cherry reporter mice with other skeletally specific 
lines that we have in house which utilize different spectrally distinct GFPs. This allows 
us to more easily break down a complex process such as endochondral ossification into 
its molecular parts.  
Work by others and recent studies in our lab have suggested that Osterix 
expression may occur earlier than appreciated being present in multipotent BMSCs [36, 
39]. Therefore, because of the struggles that the field has with identifying a multipotent 
BMSC, we have created and characterized an Osterix-Cherry Reporter mouse where 
these potentially important cells are marked with a cherry fluorescent protein.  Early 
identification of a putative BMSC based on fluorescence and cell surface profiling will 
allow for easier isolation.  Since bone marrow isolates are currently being used in various 
therapeutic applications, identifying the BMSC will hopefully lead to better clinical 
outcomes/ increased therapeutic potential.   
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CHAPTER II: SPECIFIC AIMS 
 
Multipotent skeletal progenitor cells that reside in the bone marrow and contribute 
to the maintenance and repair of bone tissue are difficult to identify and, as a result, 
remain poorly understood.  Osterix is a zinc finger transcription factor, which functions 
as a key regulator of bone formation.  Cells of the osteoblast lineage generate bone tissue 
by depositing a mineralized matrix [1, 2].  Osterix is selectively expressed in cells of the 
osteoblast lineage and has an essential function in osteoblast commitment and bone 
formation [1, 3].  While it is generally accepted that Osterix is expressed in early 
osteogenic precursors [3, 5-7], recent studies from our lab and others have suggested that 
Osterix may be expressed at an even earlier stage of the lineage, being present in a 
multipotent bone marrow skeletal progenitor cell population, which can be expanded in 
vitro as a bone marrow mesenchymal stem cells (BMSCs). 
  To further explore the expression of Osterix in early bone marrow skeletal 
progenitor cells, we have generated Osterix-Cherry reporter mice. Preliminary 
characterization of this animal model suggests reporter expression accurately represents 
endogenous Osterix expression, being largely restricted to skeletal tissues. Additionally, 
FACS isolation, replating, and differentiation of Osterix-Cherry+ bone marrow derived 
stromal cells provide evidence of their skeletal multipotency, indicated by their ability to 
differentiate into osteoblasts, adipocytes and chondrocytes.  Based on our preliminary 
data, we have formulated the following hypothesis: 
Osterix expression identifies a multipotent bone marrow skeletal progenitor cell 
population. 
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AIM 1: TO CHARACTERIZE THE EXPRESSION OF OSTERIX REPORTER MICE 
DURING SKELETAL DEVELOPMENT 
 
Temporal analysis of Osterix reporter expression will be carried out at embryonic, 
post natal and adult ages. Reporter expression will first be grossly examined 
macroscopically followed by a more detailed characterization in tissue section.  In this 
analysis, Osterix reporter mice will also be intercrossed with previously generated 
osteoblast reporter mouse models to aid in its characterization. Osterix reporter 
expression will also be compared to endogenous gene expression by immunostaining on 
tissue sections, as well as through FACS isolation of Osterix+ and negative cells 
followed by RT-PCR. 
AIM 2: TO DETERMINE IF OSTERIX+ BONE MARROW CELLS REPRESENT A 
MULTIPOTENT SKELETAL PROGENITOR CELL POPULATION.   
 
Osterix+ bone marrow cells will be characterized to determine their identity, self-
renewal and multipotent properties.  Cell surface profiling and gene expression analysis 
will be carried out to assess the mesenchymal stem cell-like profile of Osterix+ bone 
marrow cells.  Colony forming unit assays will be carried out to determine their self-
renewal capacity.  Also, in vitro differentiation assays and transplantation will be used to 
assess the skeletal potency of Osterix+ bone marrow cells.  
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CHAPTER III: MATERIALS AND METHODS 
DNA CONSTRUCTS AND ANIMAL CARE 
 
 BAC clone RP24-362M3 was obtained from the Children’s Hospital Research 
Institute (CHORI). The BACLinkSP linking vector was generously provided by Claire 
Huxley [47].  The pLD53-SC2 and pSV1.RecA recombination vectors were generously 
provided by Shiaoching Gong [48].  The mini lambda vector was generously provided by 
Donald M. Court [49].  Transgenic animals were housed in a clean barrier facility and 
humanely treated in accordance with University of Connecticut Health Center 
institutional guidelines. The Osterix-Cherry transgenic mouse line will become available 
to the research community upon acceptance of this manuscript. 
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CLONING HOMOLOGY ARMS INTO THE BAC LINKING VECTOR 
 
 All homology arms were amplified using Phusion DNA Polymerase (New 
England BioLabs) in a C1000 Thermal Cycler (BioRad).  An overlapping PCR scheme 
was used to simultaneously clone homology arms flanking the Osterix gene into 
BACLinkSP. For this, homology arm 1 (A1) was amplified using oligos 5’Arm1OLPCR 
(sense) 5’-
AGCTAAGGCTGGGCTTTCTTGATTTGTCTGGTGTGCATGCACCACCATGCCCA
GTGACAA-3’ and 3’Arm1Mlu (antisense) 5’-
CTTCACGCGTCACTAACAAACGCTTCTATAATCCTTAC-3’ which contained an 
Mlu1 site.  Homology arm 2 (A2) was amplified using 5’Arm2BamH1 (sense) 5’-
CTCTGGATCCGAGGGAGGAGGATCTTGACCAGCATCA-3’ which contained a 
BamH1 site and 3’ OLPCRArm2 (antisense) 5’-
TTGTCACTGGGCATGGTGGTGCATGCACACCAGACAAATCAAGAAAGCCCAG
CCTAGCT-3’.  PCR amplified homology arms were run out on a 1% agarose gel and gel 
purified using a Zymoclean Gel DNA Recovery Kit (Zymo Research). The purified PCR 
products were eluted in 10 ul of water and diluted 1:10 in water and combined into a 
single tube.  To promote annealing of the overlapping region, homology arms were 
heated to 95°C and a seven minute cool down was implemented followed by thermal 
cycling (95°C - 55°C - 72°C) for 25 cycles.  After 25 cycles, 5’ Arm2BamH1 or 3’ 
Arm1Mlu1 primers were added to the reaction and the reaction was allowed to proceed 
for an additional 20 cycles.  The resultant band was gel purified, restriction endonuclease 
digested with BamH1 and Mlu1, and cloned into the BamH1 and Mlu1 sites of 
pBACLinkSP using conventional cloning practices to create BACLinkSP-A1/A2.
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SUBCLONING INTO BACLINKSP-A1/A2 TO CREATE BACLINKSP-OSTERIX 
 
 The Red Recombinase System was introduced into RP24-362M3 containing 
DH10B cells by electroporation of a mini lamda vector [49-52].  Transformants were 
selected on Chloramphenicol (12.5 ug/ml) plus tetracycline (10 ug/ml) LB agar plates 
and grown at 30°C.  RP24-362M3 and mini-lambda-containing DH10B cells were made 
electrocompetent.  Prior to harvesting cells to make them electrocompetent, bacteria were 
grown at 30°C and heat shocked at 42°C for 15 minutes to activate the Red Recombinase 
System.   
 To subclone the Osterix gene into BACLinkSP-A1/A2, XhoI was used to digest 
BACLinkSP-A1/A2 and expose the ends of homology arms 1 and 2.  The linearized 
vector was then electroporated into RP24-362M3 and mini-lambda containing cells and 
selected for on LB agar plates containing Spectinomycin (50 ug/ml).  Recombinants were 
screened by colony PCR with five separate primer pairs.  Two primer pairs were 
designed to flank homology arms A1 and A2.  Primer pairs flanking homology arm 1 
were: Ost 5’Arm1Recom (sense) 5’-CTACATGATGATTCAGAACCATCTGTAACT-
3’ and Belo2658 (antisense) 5’-TTTGTCACAGGGTTAAGGGC-3’.  Primer pairs 
flanking homology arm 2 were Ost 3’Arm2Recom (antisense) 5’-
CAGACAAATCAAGAAAGCCCAGCCTTAGCT-3’ and SP2 sense 5’-
GCCCTACACAAATTGGGAGA-3’.  The three remaining primer pairs amplified 
different regions within the Osterix subclone region and were used to confirm that the 
entire region was transferred.  These three primer pairs were OstSub5’T1 (sense) 5’-
TGGTCCAAGCCTGTGGACCAAGAAGCA-3’ and OstSub3’T1 (antisense) 3’-
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AGGAACCACCTACTGAGAGGTGGCTAT-5’; OstSub5’T2ig (sense) 5’-
TCATAATGTTTCCGTGTCACCATC-3’ and OstSub3’T2ig (antisense) 3’-
TGCATGCGCTCTTGTGCATATGTACAT-5’; OstSub5’T3 (sense) 5’-
CTTAGCAGACACATACCCGAGGATGA-3’ and OstSub3’T3 (antisense) 3’-
ACTGAGTCCTCTGCACCAGTTGTAAG-5’.  BAC subclones positively identified by 
colony PCR were then further verified by Not1 and Mlu1 restriction endonuclease 
digestion followed by field inversion gel electrophoresis.  
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HOMOLOGY ARM CLONING INTO PLD53 TO CREATE PLD53-CHERRY-
OSTERIX 
 
A 462 base pair homology arm located just upstream of the second translational 
start site of Osterix was inserted into a pLD53.SC2-Cherry vector using standard cloning 
practices.  The homology arm was PCR amplified using Phusion DNA polymerase using 
the RP24-362M3 BAC as a template.  Primers Ost5’Asc1 (sense) 5’-
CTCTGGCGCGCCGTAGCTGAGGATGACCTGAGGTTC-3’ and Ost3’Sma1 
(antisense) 3’-CTCTCCCGGGGACTGGAGCCATAGTGAGCTTCTTC-5’ were used to 
amplify the homology arm.  Amplified products were run through a PCR clean up 
column (Qiagen) to reduce unincorporated nucleotides, then restriction endonuclease 
digested with AscI and SmaI for three hours.  The pLD53.SC2-Cherry vector was also 
restriction endonuclease digested with AscI and SmaI for three hours.  After digestion, 
the homology arm was gel purified using a Zymoclean Gel DNA Recovery Kit (Zymo 
Research).  The pLD53.SC2-Cherry vector was briefly treated with calf intestinal 
alkaline phosphatase (New England BioLabs) followed by a 1:1 phenol: chloroform 
extraction and precipitation. Vector and insert were mixed and ligated at room 
temperature for an hour using Quick Ligase (New England BioLabs) followed by 
electroporation into competent PIR2 cells.  Bacteria were allowed to recover for a half 
hour before selection.  Possible clones were selected for on LB plates containing 
ampicillin (50 ug/ml) and identified by colony PCR screening followed by diagnostic 
restriction endonuclease digestion with AscI and SmaI.   
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REPORTER GENE INSERTION TO CREATE BACLINKSP-OSTERIX-CHERRY 
 
In preparation for reporter gene insertion into BACLinkSP-Osterix, 50 ng of 
pSV1.RecA was transformed into DH10B cells containing BACLinkSP-Osterix.  After 
transformation, bacteria were allowed to recover for one hour without antibiotic selection 
followed by selection on LB agar plates containing Spectinomycin (50 ug/ml) and 
tetracycline (10 ug/ml) at 30°C overnight.  DH10B cells containing BACLinkSP-Osterix 
and pSV1.RecA were made electrocompetent. 
pLD53.SC2-Cherry-Osterix (1 ug) was electroporated into 50 ul of 
electrocompetent bacteria containing the pSV1 vector and BACLinkSP-Osterix.  Bacteria 
were grown in 1 ml of LB without antibiotic selection for 1 hour at 30°C.  5 ml of LB 
media containing Spectinomycin (50 ug/ml), Ampicillin (50 ug/ml) and Tetracycline (10 
ug/ml) were then added to the electroporated cells and the culture was grown overnight at 
30°C.  200 ul of the overnight culture was spread on to an agar plate containing 
Spectinomycin (50 ug/ml) and Ampicillin (50 ug/ml) and grown at 42 °C overnight.  
Colonies were picked and screened using primers that flanked the homology arm; 
OsterixRecom (sense) 5’-GCCATCACACCAAGCCTGCTTTGTGT-3’ and 
CherryGenotype (antisense) 5’-GCACCTTGAAGCGCATGAACTCCTTGATGA-3’.  
Potential BACLinkSP-Osterix-Cherry clones which were positively identified by PCR 
were then further verified by diagnostic restriction endonuclease digestion followed by 
field inversion gel electrophoresis. 
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PREPARATION OF BACLINKSP-OSTERIX-CHERRY FOR PRONUCLEAR 
INJECTION 
 
Verified BACLinkSP-Osterix-Cherry clones were grown and purified from 200 
ml of bacterial culture using a Maxi kit (Qiagen) with minor modifications detailed here. 
After alkaline lysis 2M potassium acetate was used in place of the standard 3M solution.  
QF buffer was heated to 65 °C for elution and the column eluate was further cleaned up 
with a 1:1 phenol: chloroform extraction followed by a chloroform extraction.  10 ug of 
the purified BACLinkSP-Osterix-Cherry was linearized with a SalI restriction enzyme 
digest and further purified on a Sepharose CL-4B  column (Sigma) that had been 
equilibrated with injection buffer (10 mM Tris pH 7.5, 0.1 mM EDTA, 100 mM NaCl). 
Ten 200 ul fractions were collected and the DNA was quantified using a Nanodrop 
spectrophotometer (Thermo Scientific).  30 ul of each fraction was run on a pulse field 
gel to assess DNA quality.  Pronuclear injection was carried out at the UCONN Health 
Center Gene Targeting and Transgenic Facility (GTTF).   
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HISTOLOGICAL PREPARATION OF TISSUE SAMPLES 
 
Selected tissues were dissected and fixed in 10% Formalin buffered in PBS for 4 
days at 4 °C. Hind limbs from two week old or older mice were decalcified in 15% 
EDTA for 4 to 7 days, depending on animal age. Tissues were then placed in 30% 
sucrose overnight and finally embedded in Cryomedia (Thermo Scientific).  Frozen 7 um 
sections were obtained using a Leica Cryostat and Cryofilm type II tape transfer system 
(Section-Lab Co. Ltd.).  Sequential tissue sections were mounted using 50% glycerol 
buffered in PBS for imaging. 
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MICROSCOPY AND IMAGING 
 
Whole mount images of embryonic animals and kidneys were taken using a Zeiss 
SteREO Lumar V.12 fluorescent microscope at 9.6X and 15.4X magnification using 
Cherry (HQ577/20 Ex, HQ640/40 Em) and EYFP (ET500/20 Ex, ET535/30 Em) filter 
sets (Chroma Technologies) and photographed with an Axiocam MRm digital camera 
(Zeiss).  Exposure times were adjusted for optimum imaging, and kept consistent 
throughout the experimental time course.  
Tissue sections and cultures were imaged on a Zeiss Observer Z.1 microscope 
using Cherry (HQ577/20 Ex, HQ640/40 Em, Q595lp beam splitter), EYFP (HQ500/20 
Ex, HQ 535/30 Em, Q515lp beam splitter), DAPI (AT350/50x Ex; ET460/50m Em, 
T400lp beam splitter) filter sets (Chroma Technologies). In some cases, the same tissue 
section was then stained with Mayer’s hematoxylin (Poly Scientific) and photographed 
using an Axiocam MRc and digital camera (Zeiss) also on the Zeiss Observer Z.1 
microscope.  
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IMMUNOSTAINING FOR ENDOGENOUS OSTERIX 
 
Tissue sections were dried for 30 minutes at room temperature and then 
rehydrated by rinsing in PBS for 15 minutes. Sections were then permeabilized for 30 
minutes in 0.1% Triton X-100 (Sigma) at room temperature.  Afterwards, sections were 
washed twice for 10 minutes in PBS at room temperature.  Non-specific staining was 
blocked with a 1% BSA and 5% goat serum solution (Invitrogen) in PBS for one hour.  
The blocking solution was removed, and the section was incubated in an Osterix rabbit 
polyclonal IgG  primary antibody (Santa Cruz Biotechnologies A-13, sc-22536) at a 
1:2000 dilution in 1% BSA and 1% goat serum in PBS overnight at 4 °C.  Tissue sections 
were then washed three times at 10 minutes per wash in PBS.  Tissue sections were then 
suspended in a solution containing the secondary antibody, goat anti-rabbit Alexa Fluor 
488 (Invitrogen) at a 1:500 dilution in 1% BSA and 1% goat serum in PBS.  Tissue 
sections were incubated with the secondary antibody at room temperature in the dark for 
two hours.  Sections were then washed three times for ten minutes each in PBS and 
mounted on slides in 50% PBS-buffered glycerol for imaging. 
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HARVESTING AND FACS ISOLATION OF PRIMARY CELLS FROM CALVARIA 
AND LONG BONE  
 
Five to seven day old mice were sacrificed and dissected to obtain their skulls and 
hind limbs.  Soft tissues were grossly removed with a scalpel and calvaria and hind limb 
long bones were placed in ice cold PBS. Cells were enzymatically digested from bone 
tissue in a solution containing 0.625 mg/ml Collagenase P (Roche) and 0.01% Trypsin 
EDTA (Invitrogen) in PBS.  Bone tissues were initially digested for 15 minutes in a 37°C 
shaker, and the supernatant from the first digestion was discarded.  Three subsequent 
digestions were carried out for 20 minutes each.  Cells from these three digestions were 
pooled,  run through a 70 µM strainer, centrifuged at 300 x g and resuspended in 49% 
PBS, 49% OPTI-MEM (Gibco) and 2% FBS. Prior to FACS sorting, cells were filtered 
again through a 5 ml round bottom 40 µM cell strainer capped FACS tube (Falcon) and 
kept on ice. FACS isolation was carried out using a Vantage SE FACS sorter (BD 
Biosciences) at the University of Connecticut Health Center Flow Cytometry Facility.  
Cells were collected in 20% serum in a 1:1 mixture of OPTI-MEM (Gibco) and PBS on 
ice. 
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RNA EXTRACTION 
 
A Nucleospin RNA/Protein Kit (Macherey-Nagel) was used to extract the RNA 
from sorted cell populations.  In brief, cells were lysed in RA1 buffer containing B-
mercaptoethanol.  The resultant mixture was filtered through a column, in which the cell 
lysate was cleared.  Ethanol was added to the filtrate and the mixture was spun through a 
second column, where the RNA binds to the column matrix and proteins flow through. 
The column membrane was desalted and then the DNA was digested, yielding a pure 
RNA sample in the column. The column was then washed twice with ethanol and eluted 
in 40 ul of RNase-free water.  RNA concentrations were measured with a Nanodrop 
spectrophotometer (Thermo Scientific). 
 RNA was extracted from kidneys at different ages.  Isolated kidneys were placed 
in Trizol (Invitrogen) and homogenized.  Following the chloroform extraction, RNA was 
further purified through consecutive 1:1 phenol: chloroform extractions until the interface 
between aqueous and organic layers appeared clean.  Samples were then chloroform 
extracted and precipitated in isopropanol.  RNA pellets were washed in 75% ethanol and 
resuspended in DEPC treated water.   RNA concentrations were measured with a 
Nanodrop spectrophotometer (Thermo Scientific) and RNA integrity was confirmed by 
gel electrophoresis. 
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CDNA SYNTHESIS 
 
RNA samples were first treated with DNAse I (Invitrogen) for 15 minutes at room 
temperature to remove possible genomic DNA contamination.  25 mM EDTA 
(Invitrogen) was added to each sample and samples were incubated at 65 °C for 10 
minutes to inactive DNAse I.  A master mix containing first strand buffer, random 
primers, DTT, and dNTPs were added to each sample.  Samples were then incubated for 
10 minutes at 65 °C followed by incubation on ice.  RNaseOUT recombinant 
ribonuclease inhibitor (Invitrogen) and M-MLV reverse transcriptase (Invitrogen) were 
added to each tube.  Samples were mixed and incubated at 37°C for 1.5 hours, and then 
the M-MLV was heat inactivated at 85 °C for 10 minutes.   
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PCR AMPLIFICATION FOR OSTERIX MRNA ISOFORMS 
 
mRNA isoform specific primers were designed using Vector NTI software 
(Invitrogen) and the NCBI database / Primer-BLAST.   mRNA1 was selectively amplified 
using primer sets: Exon1-2 5’ (sense) 5’-TTCTCTCCATCTGCCTGACTCCTT-3’, 
Exon1-2 3’ (antisense) 5’- CCATTGGTGCTTGAGAAGGGAGCTG-3’. mRNA2 was 
selectively amplified using primer sets:  Exon2 5’ (sense) 5’-
AGGCCACCCATTGCCAGTAA-3’, Exon 2 3’ (antisense) 5’-
GTCATTTGCATAGCCAGAGGCTGG-3’.  PCR amplification was also carried out for 
the Cherry reporter gene: Cherry2 5’ (sense) 5’-CATCCCCGACTACTTGAAGC-3’ and 
Cherry2 3’ (antisense) 5’- CTTCAGCTTCAGCCTCTGCT-3’ and GAPDH: GAPDH5’ 
(sense) 5-CATGTTCCAGTATGACTCCACTC-3’ and GAPDH3’ (antisense) 5’-
GGCCTCACCCCATTTGATGT-3’. PCR amplification was carried out using standard 
methodologies using a C1000 Thermal Cycler (BioRad).  
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MAINTENANCE OF ANIMALS 
 
Osterix-Cherry mice were generated by Sara Strecker [53]. Transgenic animals 
were housed in a clean barrier facility and humanely treated in accordance with 
University of Connecticut Health Center institutional guidelines. BSP transgenic mice 
were generated by Peter Maye [54]. Mice were cared for by the Center of Animal Care 
(CLAC) at the University of Connecticut. Mice were monitored twice weekly by 
veterinary technicians. The Gene Targeting and Transgenic Facility (GTTF) injected the 
BAC DNA construct into the mouse. If mice showed signs of stress, they were 
euthanized.  Adult mice were sacrificed using CO2 inhalation and subsequent cervical 
dislocation, as published by CLAC.  Neonatal mice were sacrificed via hypothermia 
followed by decapitation.  The animal protocol used is 2010-605. 
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IMAGE ANALYSIS  
 
The image analysis of the cortical sections was completed with the assistance of 
Max Villa at the University of Connecticut, Storrs, CT.  Briefly, a Euclidean Distance 
Analysis was performed on multiple fluorescent images of cortical sections using the 
Image J program (NIH, [55]). The inner cortical surface was selected and a region of 
interest was generated. The image was converted to grayscale and a Euclidean Distance 
Map was generated where a white (value 0) pixel was at the center of the marrow and a 
black (value 255) pixel was the cortical edge.  The rest of the image was coded such that 
the distance from the center to the edge was repented by different grayscale values.  A 
duplicate of the original florescent image was then converted to a binary image. The 
distance information for the Euclidean Distance Map was combined with the binary 
image and a histogram was calculated, which showed the number of Cherry+ pixels as a 
function of distance from the endocortical surface[56, 57]. 
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ALKALINE PHOSPHATASE STAINING 
 
Two stock solutions were created at a concentration of 50mg/ml.  Fast Blue BB 4-
benzoylamino-2, 5-diethoxybenzenediazonium chloride hemi [zinc chloride] salt (Sigma) 
was dissolved in dimethyl formamide.  NAMP 3-hydroxy-2-naphthoic acid 2, 4-
dimethylanilide phosphate (Sigma) was dissolved in dimethyl sulfoxide. Both stock 
solutions were stored at -20°C.  
Staining solutions were prepared immediately prior to use. An SB8.2 solution, 
containing 0.1M Tris, pH 8.0, 50mM MgCl2, 100mM NaCl and 0.1% Tween20 was 
prepared.  Stock solutions were diluted in the staining solutions separately, such that each 
staining solution contained 500ug/ml of either Fast Blue or NAMP.  The staining 
solutions were mixed together in equal parts and immediately applied to the tissue 
section.  Sections were stained for 3 minutes, rinsed in PBS and immediately cover-
slipped with a 50% Glycerol, 50% PBS mixture.   Staining can be visualized as blue or 
imaged under the Cy5 (ET620/60x Ex, ET700/75m Em, T660lpxr beam splitter) filter.  
Osterix- Cherry was imaged under the Cherry (HQ577/20 Ex, HQ640/40 Em, Q595lp 
beam splitter) filter.   
 
  
 
 
39 
 
IMMUNOSTAINING FOR CD31 
 
Tissue sections were dried for 30 minutes at room temperature and then 
rehydrated by rinsing in PBS for 15 minutes. Sections were then permeabilized for 30 
minutes in 0.1% Triton X-100 (Sigma) at room temperature.  Afterwards, sections were 
washed twice for 10 minutes in PBS at room temperature.  Non-specific staining was 
blocked with a 5% donkey serum solution in PBS for one hour.  The blocking solution 
was removed, and the section was incubated in a CD31 (R&D Systems AF3628) at a 1:20 
dilution in 1% donkey serum in PBS overnight at 4 °C.  Tissue sections were then 
washed three times at 10 minutes per wash in PBS then suspended in a solution 
containing the secondary antibody, donkey anti-goat Dylight 488 (Jackson Immuno 
Research Labs, 705-486-147) at a 1:3500 dilution in 1% donkey serum in PBS.  Tissue 
sections were incubated with the secondary antibody at room temperature in the dark for 
two hours.  Sections were then washed three times for ten minutes each in PBS and 
mounted on slides in 50% PBS-buffered glycerol for imaging. 
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PREPARATION OF BONE MARROW STROMAL CELLS FOR CULTURE AND 
SORT 
 
Osterix-Cherry mice were used both for cell surface profiling directly from the 
marrow and to derive BMSC cultures. In brief, 3-4 week old mice were sacrificed by CO2 
asphyxiation followed by cervical dislocation. Femurs and tibia were dissected from the 
surrounding tissues. The bones were cut through the mid-diaphysis and the bone marrow 
was collected through centrifugation.  In brief, eppendorf tubes, each containing a filter-
less column, were prepared.  200 ul of sterile cold PFE (98% PBS, 2% FBS, 2 mM 
EDTA) were added to the bottom of the eppendorf tube.  Bones were placed, cut side 
down into the column and spun at high speed for 3 minutes. Single cell suspensions were 
prepared by gently mixing the cells with a pipette followed by filtration through a 70 μm 
strainer.   Cells which were to be analyzed immediately were subjected to a red blood cell 
lysis.  For the red blood cell lysis, the cells were pelleted by spinning for 5 minutes at 
350g and 1 ml of Red Blood Cell Lysing Buffer (Sigma, R7757) was added to the pellet.  
This was gently mixed for one minute than placed on ice for three minutes.  The Red 
Blood Cell Lysing Buffer was diluted with 10 ml of PBS and then the cells were 
centrifuged at 350g for 7 minute.  The supernatant was decanted and the cells were 
prepared for further profiling. 
  Cells which were to be cultured did not undergo Red Blood Cell Lysis and were 
plated at a density of 1.2 × 10
6
 cells/cm
2 in αMEM culture medium containing 100 U/ml 
penicillin, 100 μg/ml streptomycin and 10% FCS (Hyclone). At day 4, the media was 
changed. On day 5, the cells were sorted and processed.  In some cases, cells were 
cultured for a 21 day time period.  In these cases, cells were grown in αMEM culture 
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medium containing 100 U/ml penicillin, 100 μg/ml streptomycin and 10% FCS 
(Hyclone) for 7 days, with the media being changed on Day 4 and Day 7.  On Day 7, the 
media was supplemented with 50 μg/ml ascorbic acid and 8 mM 2-glycerol phosphate 
and changed every two days until Day 21. 
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FACS ANALYSIS 
 
Cultured cells were washed twice with cold PBS then digested using a sterile 
filtered mixture of 0.1% Collagenase P (Roche), 0.1% Hyaluronidase (Sigma), 2% FBS 
(Hyclone), 49% OPTI-MEM (Gibco) and 49% PBS (Gibco).  Cells were digested for 10 
minutes at 37°C, scraped, then digested for an additional 5 minutes at 37°C.  The 
digestion was stopped using an equal amount of media containing 2% FBS, 49% PBS 
and 49% OPTI-MEM.  At this point, cultured cells and cells from the marrow were 
treated in the same manner.  Cells were counted and then centrifuged at 300g for 10 
minutes.  Up to 10
7
 nucleated cells were resuspended in 100 ul FACS staining buffer 
(PBS, 0.5% BSA, 2 mM EDTA, pH 7.2).  10 ul of the appropriate antibody was then 
added to the cell suspension.  This was mixed well and incubated for 10 minutes in the 
dark at 4 °C.  Next the cells were washed by the addition of 1-2 ml of buffer and 
subsequent centrifugation at 300 g for 10 minutes.  The supernatant was aspirated and the 
cells were resuspended in 500 ul of staining buffer for FACS analysis.    
Antibodies used were all conjugated to APC in order to be spectrally distinct from 
the Cherry and included CD11b (Miltenyi, 130-091-241), CD31 (Miltenyi, 130-097-420), 
CD45 (Miltenyi, 130-091-811),  CD44 (Miltenyi, 130-096-836),  CD140b (Miltenyi, 
130-096-270) CD105 (Miltenyi, 130-092-930), Anti-Sca1 (Miltenyi, 130-093-223), 
CD29 (Miltenyi, 130-096-356) and CD90.2 (Miltenyi, 130-091-790).  Cells were 
analyzed on the FACS LSRII (BD) using the Red 649 nm Laser (670/30) and the YS 561 
nm Laser (610/20, 600LP). The Blue 488 nm Laser (530/30, 505LP) was sometimes used 
to gate out auto-fluorescent cells.  
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FACS SORTING 
 
Cells from the bone marrow were sorted using the 70 um nozzle on the FACS 
Aria (BD).  Cells which had been cultured were also sorted on the FACS Aria, however 
the 130 um nozzle was used. Cells were sorted for mCherry using the Green Laser 
(610/20, 600LP), APC using the Red Laser (660/20) and GFP using the Blue Laser 
(530/30, 505LP).   Cells were originally sorted into media containing 20% FBS 
(Hyclone), 40% PBS (Gibco) and 40% OPTI-MEM (Gibco). However, our current 
research is suggesting that the cells remain viable for a longer period of time if they are 
sorted into media containing 2% FBS (Hyclone), 49% PBS (Gibco) and 49% OPTI-
MEM (Gibco), therefore, sorts conducted in Chapter I were sorted into 20% serum 
containing media and sorts conducted in Chapter II were sorted into media containing 2% 
serum. 
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DIFFERENTIATION OF ISOLATED CELL POPULATIONS 
 
After FACS, isolated cell populations were initially plated as a spot with 
~ 2 × 10
4
 cells in 10 μl of medium (αMEM culture medium containing 100 U/ml 
Penicillin, 100 μg/ml streptomycin and 10% FCS (Hyclone)) for osteogenic and 
adipogenic differentiation.   2 × 10
6
 cells were plated in a 10 ul spot for chondrogenic 
differentiation.  After 2 hours, αMEM culture medium containing 100 U/ml penicillin, 
100 μg/ml streptomycin and 10% FCS (Hyclone) was added to the spot cultures.  
Osteogenic differentiation was induced with the addition of 50 μg/ml ascorbic acid, and 
8 mM 2-glycerol phosphate to the culture media on Day 1 and cells were maintained in 
differentiation media for 8 days. Adipogenic differentiation was induced with the 
addition of 1.0 uM insulin and 0.5 uM Rosiglitizone to the culture media on Day 1 and 
cells were maintained in differentiation media for 8 days.  Chondrogenic differentiation 
was induced on Day 1.  Cells were cultured in high glucose DMEM which was 
supplemented with ITS+1, 50 μg/ml ascorbic acid, 100 μg/ml sodium pyruvate, 0.1 uM 
dexamethasone,  100 U/ml penicillin, 100 μg/ml streptomycin, 40 μg/ml L-proline and 10 
ng/ml TGF-Β3. 
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HISTOLOGICAL EVALUATION OF ISOLATED CELL POPULATIONS 
 
Osteogenesis was assessed through von Kossa staining. Cultures were washed 
with PBS then  fixed in 10% formalin for 10–15 min. Cultures were next rinsed with 
water and a 5% silver nitrate solution was added.  Cross-linking to evaluate the amount of 
phosphate deposition was performed for 2 cycles at 1200 µjoules × 100 in a UV 
Stratalinker (Stratagene, La Jolla, CA). Mineralized nodules appear as dark spots. 
Cultures counterstained with Mayer’s Hematoxylin.  
Adipogenesis was assessed through Oil Red O staining. In brief, cultures were 
washed in PBS and fixed for 10 minutes in 10% formalin.  After fixation, cultures were 
washed with water and air dried.  The 0.5% stock Oil Red O solution was diluted to 
0.3%, filtered through Whatman #1 filter paper, and then added to the dry cultures.  This 
was incubated for 1 hour at room temperature and the stain was aspirated.  Cultures were 
washed twice with water and counterstained with Mayer’s Hematoxylin.  
Chondrogenesis was assessed through Alcian Blue staining.  Cultures were rinsed 
with PBS then fixed with 10% formalin for 10 minutes.  Cultures were then briefly rinsed 
with a solution of 3% glacial acetic acid (pH 1.0).  Alcian blue staining was carried out 
overnight using a 1% Alcian Blue solution (pH 1.0).    Excess staining was removed 
through a wash in 3% glacial acetic (pH 1.0) and then two washes with 3% glacial acetic 
acid (pH 2.5).    
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CHAPTER IV: GENERATION AND CHARACTERIZATION 
OF OSTERIX-CHERRY REPORTER MICE 
See Appendix for Copyright  
 
ABSTRACT 
Osterix is a zinc finger containing transcription factor and functions as a key 
regulator of osteoblast differentiation.  To better understand the temporal and spatial 
expression of Osterix during embryonic development and in the adult skeleton, we 
generated Osterix-Cherry reporter mice.  Bacterial recombination techniques were 
employed to engineer a transgenic construct, which consisted of a ~39kb DNA fragment 
encompassing the Osterix/Sp7 gene, but excluding adjacent gene sequences.  Osterix 
reporter expression was characterized at embryonic, neonatal, and adult ages both by 
itself and in the context of a cross with Bone Sialoprotein (BSP)-Topaz reporter mice. 
Relative to Osterix, BSP is a more mature marker of osteoblast differentiation.  In 
agreement with osteoblast lineage maturation, Osterix reporter expression preceded BSP 
reporter expression during embryonic development and spatially appeared in a much 
broader cell population. Strong Osterix reporter expression was observed in mature 
osteoblasts and osteocytes.   However, weaker Osterix-Cherry+ cells were also observed 
in the bone marrow, possibly identifying an early osteoprogenitor cell population.  
Evaluation of Osterix reporter expression in male femur tissue sections from 10 days to 
12 weeks of age revealed persistent expression in cells of the osteoblast lineage and a 
surprising increase in maturing chondrocytes of the growth plate. Also, Osterix reporter 
expression was transiently detected in the kidney after birth.   
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INTRODUCTION 
 
Bone development occurs through two different processes termed 
intramembranous ossification and endochondral ossification [6, 58-60].  Most bones of 
the craniofacial skeleton develop through intramembranous ossification, where 
mesenchymal cells directly differentiate into cells of the osteoblast lineage.  However, in 
the axial and appendicular skeleton, all bones develop through endochondral ossification, 
in which mesenchymal cells first condense and differentiate into chondrocytes that form 
cartilaginous anlagen.  The cartilaginous anlagen serves as a physical template for bone 
formation and chondrocytes within the anlagen signal to the outer perichondrium, 
providing critical signaling cues that coordinate the colonization/replacement of cartilage 
by bone. 
 Genetic studies in mice have revealed that Osterix is a key transcriptional 
regulator of osteoblast differentiation and, more recently, of chondrocyte maturation.  
Osterix is a Cys2-His2 type zinc finger protein that binds DNA and belongs to the SP1 
family of transcription factors [1].  In Osterix global knockout mice, the initial 
establishment of a cartilaginous skeleton appears grossly normal, but osteoblast 
differentiation fails to occur, leading to perinatal lethality [1].  Global inactivation of 
floxed Osterix at postnatal and adult ages using Cag-CreER mice resulted in loss of 
osteoblasts on the bone surface and progressive deterioration of bone tissue, revealing 
that Osterix continues to have an essential role in maintaining bone tissue at adult ages 
[3].  Selective deletion of Osterix with Col2a1-Cre has also revealed an important role for 
Osterix in chondrocyte maturation.  Loss of Osterix in chondrocytes resulted in an 
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expanded hypertrophic zone that failed to completely mature, resulting in a significant 
delay and reduction in vascular invasion and bone remodeling by osteoclasts [43].     
 
 
49 
 
RESULTS 
 
To increase our understanding of Osterix gene expression at embryonic and adult 
ages, we generated Osterix-Cherry reporter mice.  The Osterix gene is located in a 
relatively gene rich area on mouse chromosome 15.  Therefore, in designing the 
transgene, we decided to separate Osterix from these neighboring genes by subcloning a 
39kb DNA fragment containing the Osterix gene using a bacterial recombination 
approach (Fig.2A).  This subcloned DNA fragment includes 24457 bp of sequence 
upstream of the first translational start site and ends 6920 bp downstream of the stop 
codon. To verify the isolated region‘s identity, Not1 and Mlu1 restriction endonuclease 
digests were carried out. Two predicted bands, one at approximately 22 kb and the 
second at 25 kb were observed, thereby identifying three positive clones (Fig. 2B).  Work 
by others [2, 41] and our own alignment of mRNA transcripts deposited into the NCBI 
database have shown that Osterix transcription yields two alternatively spliced mRNAs.  
mRNA1 encodes for a slightly larger 428 amino acid  isoform whose translation starts in 
exon 1, while mRNA2 encodes for a shorter 410 amino acid isoform whose translation 
starts in exon 2 (Fig. 2C).  The second downstream translation start site is in frame with 
the upstream translation start site.  Therefore, we decided to insert a Cherry fluorescent 
protein reporter just upstream of the second translation start site in order to detect both 
Osterix isoforms (Fig.2C, red arrow head).  To confirm the targeted insertion of the 
Cherry reporter, colony PCR was carried out using primers that flank the 462 bp 
homology box (Fig. 2D).  Pronuclear injection of the DNA construct resulted in 
generation of two different founder lines.  Gross evaluation of reporter gene expression 
from F1 and F2 offspring from both founder lines showed identical expression patterns 
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(data not shown).  Thereafter, we have primarily focused on one founder line and present 
a more detailed characterization of its reporter gene expression here.   
FIGURE 2: ASSEMBLY OF OSTERIX-CHERRY TRANSGENE 
(a) A 39 kb region containing the Osterix gene and flanking DNA sequences was subcloned from BAC clone RP24-362M3 into 
BACLink-SP. (b) Potential subclones were confirmed by a diagnostic restriction endonuclease digestion with Mlu1 and Not1, which 
showed two DNA fragments at 25 and 22 kb. (c) Diagram of the Osterix gene (black) mapped with two alternatively spliced mRNA 
transcripts (blue). Two alternative translational start sites also exist. The first translational start site is located in exon 1b and results in 
the creation of a long protein isoform (mRNA1) consisting of 428 amino acids. The second translational start site is located near the 
beginning of exon 2, is in frame with the upstream translational start site, and results in the creation of a shorter protein isoform 
(mRNA2) consisting 410 amino acids. The Cherry reporter was inserted via homologous recombination just upstream of the second 
translational start site of the Osterix gene (red arrow) allowing us to detect both transcriptional isoforms. (d) Gel image of colony PCR 
screening to identify clones where the Cherry reporter was appropriately inserted into the construct. Two positive clones are shown. 
 
To aid in the characterization of Osterix-Cherry mice, we compared their reporter 
expression to that of a Bone Sialoprotein (BSP)-Topaz reporter mouse line [54].  During 
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osteoblast differentiation, Osterix expression precedes BSP and is required for BSP 
expression [61]. The BSP –Topaz reporter line utilizes a fluorescent protein that is 
spectrally distinct from Cherry fluorescent protein, allowing us to simultaneously image 
both reporters and visualize immature and mature osteoblast cell types.  Osterix-Cherry 
reporter expression (red) was characterized relative to BSP-Topaz reporter expression 
(green) from days E13.5 to E17.5 of embryonic development.   Congruent with skeletal 
development occurring asynchronously in an anterior to posterior progression, Osterix 
reporter expression was first detected at E13.5 in craniofacial bones and weakly in the 
fore limbs (Fig. 3A).  BSP reporter expression was also detected at E13.5 (Fig. 3B); 
however the domains of Osterix reporter expression were noticeably broader than those 
of the BSP reporter (Fig. 3 Compare A to B, and C). At E15.5, Osterix reporter 
expression increased relative to E13.5 and now can be detected in the ribs and hind limbs 
(Fig. 3D). Levels of BSP reporter expression have also increased from E13.5 to E15.5 
and globally appear in the same regions as Osterix (Fig.3 E and F). The progression of 
osteoblast maturation can be appreciated at higher magnification in the frontal and 
parietal bones of the skull (Fig.3 G-I) and the radius, ulna, and humerus of the fore limb 
(Fig.3 J-K).  Again, the domains of Osterix reporter expression are broader than those 
controlled by BSP and show the transition from osteoprogenitor to a maturing osteoblast.  
Both Osterix and BSP reporters at this age are osteoblast specific and do not appear in 
other connective tissue cell types such as the sutures of the skull (Fig.3 G-I) or in joints of 
the appendicular skeleton (Fig.3 J-L).  At E17.5 the expression levels of Osterix and BSP  
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reporters continued to increase (Fig.3 M-O).  Osterix and BSP reporters are now detected 
in the vertebrae and pelvic girdle.  Also, as limb development progresses in a proximal to 
FIGURE 3: COMPARISON OF 
OSTERIX REPORTER EXPRESSION 
TO BONE SIALOPROTEIN 
(a–o) Whole embryo imaging of 
reporter gene expression from E13.5–
E17. (a ,d, g, j, m) Osterix-Cherry 
reporter expression (red). (b, e, h, k, n) 
Bone Sialoprotein – Topaz reporter 
expression (green). (c, f, i, l, o) Merge 
of Osterix and Bone Sialoprotein 
reporter expression yellow indicates 
where the signals overlap). (a–c) 
Comparison of Osterix and Bone 
Sialoprotein reporter expression at 
E13.5 (a) Osterix reporter expression is 
first detected at E13.5 in the developing 
craniofacial bones and in the fore limbs. 
Very weak Osterix reporter expression 
is detected in the developing hind 
limbs. (b) The onset of Bone 
Sialoprotein reporter expression is also 
detected at E13.5. (c) The merged 
image confirms the overlap between 
both osteoblast reporter models; 
however, the Osterix reporter is 
expressed in a considerably broader cell 
population than the Bone Sialoprotein 
reporter. (d–i) Comparison of Osterix 
and Bone Sialoprotein reporter 
expression at E15.5. (d) Levels of 
Osterix reporter expression have 
increased relative to E13.5 and are now 
easily detected in the hind limbs and 
ribs in addition to the bones of the 
craniofacial skeleton and fore limb. (e) 
Levels of Bone Sialoprotein reporter 
expression have also increased since 
E13.5 and appear in the same skeletal 
elements as the Osterix reporter as 
shown in the merged image (f). 
While both reporter genes are expressed 
in the same skeletal elements, the 
broader cellular expression of the 
Osterix reporter relative to the Bone 
Sialoprotein reporter is apparent and 
appreciated at higher magnification in 
the skull (g–i) and fore limb (j–l). (m–
o) Osterix and Bone Sialoprotein 
reporter expression at E17.5. Osterix 
reporter expression is now detected in 
the vertebrae and developing digits, 
whereas the Bone Sialoprotein reporter 
is seen in the spine, but has not yet 
appeared in the metatarsals. 
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distal fashion, Osterix reporter expression is detected in the digits of the paws (Fig.3 M-
O). 
 
FIGURE 4: COMPARISON OF OSTERIX REPORTER EXPRESSION TO BONE SIALOPROTEIN REPORTER EXPRESSION IN A 
TISSUE SECTION THROUGH A 3-WEEK-OLD FEMUR. 
(a) Merged image of Osterix-Cherry (red) and Bone Sialoprotein-Topaz (green) reporter expression. Global visualization of reporter 
expression revealed that the Osterix reporter is intensely and uniformly expressed in osteoblasts within the trabecular and cortical bone 
regions. In contrast, Bone Sialoprotein reporter expression was not as uniformly expressed as the Osterix reporter and appeared at 
higher levels within the trabecular bone region and at lower levels in cortical bone. This is better appreciated at higher magnification 
[regions of interest are denoted by dashed boxes (b–d) and (e–g)]. (b and e) Osterix reporter expression was strongly expressed in 
osteoblasts and osteocytes within trabecular bone (b) and cortical bone (e). Low Osterix reporter expression was also detected in a cell 
population present in the bone marrow, but in proximity to trabecular and cortical bone surfaces. (c and f) Bone Sialoprotein reporter 
expression was strongly detected in osteoblasts and osteocytes in the trabecular bone region (c), but was expressed at lower levels and 
appeared with less frequency in osteoblasts and osteocytes present in cortical bone (f). Unlike the Osterix reporter, the Bone 
Sialoprotein reporter was not detected in any cells within the bone marrow. (d and g) Merged images reveal the expression of both 
reporters relative to each other in the trabecular and cortical bone regions. 
 
Characterization of Osterix-Cherry reporter expression was also compared to BSP-Topaz 
reporter expression in tissue sections through a 3 week old femur (Fig. 4).  The whole 
femur was imaged for both reporters (Fig. 4A) and areas of trabecular bone (Fig. 4B-D) 
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and cortical bone (Fig. 4E-G) are shown at higher magnification.  Osterix reporter 
expression was robustly and broadly expressed in cells of the osteoblast lineage (Fig. 
4A).  Strong Osterix reporter expression is present in mature osteoblasts lining trabecular 
and cortical bone surfaces and osteocytes embedded within bone tissue (Fig. 4, A, B, and 
E). In contrast, BSP reporter expression is not nearly as uniform as the Osterix reporter.  
High levels of BSP reporter expression were detected just below the growth plate within 
the trabecular bone region (Fig. 4 A and C), but gradually decreased as the distance from 
the growth plate increased, with lower BSP reporter expression being present in 
osteoblasts on the cortical bone surfaces in the mid-diaphysis region (Fig. 4 compare C to 
F).  Also, the frequency of BSP+ cells was higher on the endosteal bone surfaces relative 
to the outer periosteum (Fig. 4 F and not shown).  In addition to the Osterix reporter 
being strongly expressed in osteoblasts and osteocytes, we also noted the detection of a 
bone marrow cell population situated in proximity to bone surfaces that retained lower 
Osterix reporter expression (Fig. 4 B and E).  The BSP reporter was not detected in this 
bone marrow cell population (Fig. 4 C and F), suggesting this may be a very early 
osteoprogenitor cell type.   
 Loss of function studies at postnatal to adult ages have indicated that Osterix 
continues to play an essential role in the maintenance of bone tissue [7, 44, 62, 63].  
Consistent with these studies, the evaluation of Osterix reporter expression in male 
femurs at increasing ages (10 days, 3 weeks, 8 weeks, and 12 weeks) suggests that 
Osterix expression persists in cells of the osteoblast lineage into adulthood (Fig. 5). 
Interestingly, in this temporal analysis we also detected an increase in Osterix reporter 
expression in maturing chondrocytes of the growth plate.  In three week old animals,  
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FIGURE 5: STRONG AND PERSISTENT OSTERIX REPORTER EXPRESSION IN BONE CELLS WITH AGING. 
Osterix reporter expression and corresponding hematoxylin stained tissue sections at postnatal day 10 (a, a’) 3 weeks (b, b’), 8 weeks 
(c, c’), and 12 weeks of age (d, d’). Osterix reporter expression persisted with aging in osteoblasts and osteocytes present in the 
trabecular and cortical bone regions. Fixed exposure times were used and all femurs were taken from male mice. 
expression of the Osterix reporter was very weak in the growth plate relative to the level 
of reporter gene expression detected in the bone cells (Fig. 6A).  However, by 8 weeks of 
age, Osterix reporter expression was easily detected in maturing chondrocytes (Fig. 6B) 
and at twelve weeks of age, the area of the growth plate retaining Osterix reporter 
expression was arguably the highest expressing region within the bone (Fig. 6C).  
To determine if expression of the Osterix reporter 
represents endogenous Osterix gene expression, we 
compared Osterix reporter expression to endogenous 
levels of Osterix protein by immunostaining.  
Immunostaining for Osterix was initially carried out 
directly on bone tissue sections derived from Osterix transgenic mice.  However, we soon 
FIGURE 6: INCREASE IN OSTERIX REPORTER EXPRESSION IN GROWTH PLATE 
CHONDROCYTES WITH AGING 
(a–c) A fixed exposure time was used to compare the fluorescence intensity of Osterix 
reporter expression in growth plate chondrocytes at 3 weeks (a), 8 weeks (b), and 12 
weeks of age (c). While the Osterix reporter can be detected in growth plate 
chondrocytes in 3-week-old mice (a), there is a substantial increase in reporter 
expression detected in 8-week-old mice (b), which continues to increase with age as 
shown in 12-week-old mice (c). 
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learned that the polyclonal antibody that worked extremely well in our hands recognized 
our reporter gene.  The reason for this is that we cloned into the second exon, just 
upstream of the second translational start site, in order to detect both transcriptional 
isoforms.  In doing so, transcription and translation of mRNA1-Cherry results in the 
creation of a small protein fusion in which the first 17 amino acids of Osterix are present 
on the N-terminal of the Cherry reporter.  Correspondence with Santa Cruz 
Biotechnologies confirmed that the 
 
FIGURE 7: COMPARISON OF OSTERIX REPORTER EXPRESSION TO IMMUNOSTAINING FOR OSTERIX PROTEIN 
Osterix reporter expression (red) was compared with immunostaining for Osterix protein (green) in tissue sections of 4-week-old 
femurs [tissue sections were counterstained with DAPI (blue)]. Comparison of expression was assessed in four different regions: (a, b) 
cortical bone, (c, d) trabecular bone, (e, f) growth plate cartilage, and (g, h) articular cartilage. Osterix reporter expression was highly 
expressed in osteoblasts lining the cortical (a, white arrows) and trabecular bone surfaces (c) and osteocytes embedded in bone tissue 
(a). Immunostaining also revealed high levels of Osterix protein expression in osteoblasts lining cortical (b, white arrows) and 
trabecular bone surfaces (d), but was difficult to detect in osteocytes (b). (e) Osterix reporter expression was broadly expressed at low 
levels in growth plate chondrocytes with slightly higher levels of reporter expression present in maturing chondrocytes. (f) 
Immunostaining reveals Osterix protein was largely restricted to chondrocytes undergoing hypertrophy. At the end of the distal femur, 
Osterix reporter expression (g) and immunostaining for Osterix (h) correlate well in the articular cartilage as shown by overlapping 
signals in chondrocytes undergoing hypertrophy. (BM, bone marrow; CB, cortical bone; PS, primary spongiosa; SS, secondary 
spongiosa). 
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polyclonal antibody (A-13) was raised against this region of Osterix and therefore 
selectively detects the long protein isoform of Osterix.  Unfortunately, many other 
antibodies against Osterix were tried, but did not work well in our hands.  Alternatively, 
we decided to use the A-13 antibody on non-transgenic littermates and compare 
immunostaining (green fluorescence) to Osterix reporter expression (red fluorescence) 
(Fig. 7).  Tissue sections were counterstained with DAPI (blue fluorescence).  Four 
different regions of interest within the femur were compared; cortical bone (Fig. 7, 
compare A to B), trabecular bone (Fig. 7, compare C to D), the growth plate (Fig. 7, 
compare E to F), and the articular surface at the distal end of the femur (Fig. 7, compare 
G to H). In the cortical and trabecular bone regions, Osterix reporter expression appeared 
strongest in osteoblasts lining the bone surface (white arrows), but also had fairly high 
levels of expression in osteocytes within the bone tissue (Fig. 7 A and C).  Consistent 
with Osterix reporter expression, immunostaining for Osterix was most intense in 
osteoblasts lining the cortical (white arrows) and trabecular bone surfaces, whereas 
noticeably less protein was detected in osteocytes (Fig. 7 B and D).  As detailed earlier, 
Osterix reporter expression increased with age in maturing chondrocytes within the 
growth plate (Fig. 6).  However, by four weeks of age and relative to osteoblasts and 
osteocytes, the Osterix reporter is expressed at lower levels in chondrocytes of the growth 
plate, with slightly higher levels being present in maturing chondrocytes (Fig. 7E).  In 
contrast, immunostained Osterix protein was only detected in chondrocytes undergoing 
hypertrophy (Fig. 7E).  Unlike the differences observed between reporter and 
immunostaining in the growth plate, Cherry expression correlated well with 
immunostaining in articular chondrocytes.  In the knee joint, Osterix reporter expression 
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is absent from the most superficial zones of the articular surface in the distal femur, but 
appears in maturing chondrocytes further away from the articular surface (Fig. 7G, white 
arrows).  In a similar manner, detection of Osterix protein was also present in maturing 
chondrocytes below the articular surface (Fig. 7).  
 While Osterix immunostaining largely correlated with Osterix reporter gene 
expression, some differences were observed.  Possible reasons for these differences may 
relate to the fact that the reporter should reflect 
the expression of both transcriptional isoforms 
of Osterix, while the A-13 polyclonal antibody 
only recognized the long protein isoform.  
Additionally, post-transcriptional mechanisms 
that would regulate levels of Osterix protein 
would not be reflected in reporter gene 
expression.  
To further compare expression of the Osterix reporter to endogenous Osterix, we 
also carried out RT-PCR on reporter positive and negative cell populations that were 
isolated by FACS from neonatal calvaria and long bones (Fig. 8, A-D).  Approximately 
50% of the cells digested out of the calvaria (Fig. 8A) and 12% of the cells digested from 
FIGURE 8: GENE EXPRESSION ANALYSIS OF OSTERIX MRNA 
ISOFORMS ON FACS ISOLATED PRIMARY CELLS 
Primary cells were harvested from the calvaria and hind limb of 
Osterix reporter mice at postnatal day 5 and FACS isolated for gene 
expression studies. (a–d) FACS isolation of Osterix positive (P5- 
orange) and negative (P4-purple) cell populations from calvaria (a) 
and hind limb (c). (b, d) Nontransgenic littermate controls are also 
shown. (e) Gene expression analysis was carried out for the Cherry 
reporter gene, both transcriptional isoforms of Osterix (mRNA1 and 
mRNA2) and GAPDH. Both transcriptional isoforms are detected in 
the Cherry positive cell fraction, while mRNA2 was also weakly 
detected in the negative cell fraction. 
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long bones (Fig. 8C) were Osterix reporter positive.  RT-PCR was carried out on the 
reporter (Cherry), the individual isoforms of Osterix (mRNA1 and mRNA2), and GAPDH 
(Fig. 8E). Amplification for the Cherry reporter confirmed that FACS dramatically 
enriched for the Osterix reporter positive and negative cell populations.  Specific 
amplification for both alternative isoforms of Osterix revealed that mRNA1 was 
exclusively expressed in the reporter positive cell population, while mRNA2 could be 
detected in both cell fractions with higher levels being present in the reporter positive cell 
fraction.   
 While expression of the Osterix reporter was largely restricted to skeletal tissues, 
we also detected high levels of reporter expression for a transient period of time in the 
kidneys of newborn pups that gradually decreased by the time animals were weaned (Fig. 
9). To further characterize renal Osterix reporter expression, kidney samples were 
collected from transgenic mice at E17.5 (Fig. 9A), P4 (Fig. 9B) and 3 weeks (Fig. 9C) of 
age and the intensity of fluorescent reporter expression was compared.  Surprisingly, at 
E17.5 and 3 weeks, reporter expression was detectable, but very weak, while reporter 
expression at P4 was extremely high.   We also examined Osterix reporter expression in 6 
week and 11 week old transgenic animals, but no reporter expression was detected (data 
not shown).  Further examination of Osterix reporter expression in tissue sections of P4 
animals (Fig. 9, D, E, E’, E’’) revealed that reporter expression was present in the 
juxtamedullary nephrons, which are located in the cortex, but adjacent to the medulla 
(Fig. 9D).  Within the juxtamedullary nephrons, Osterix reporter expression was detected 
at low levels in the proximal convoluted tubules and at higher levels in the thick 
descending limb of the loop of Henley (Fig. 9, E’ and E”).  
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FIGURE 9: TRANSIENT OSTERIX REPORTER EXPRESSION IN THE KIDNEY 
(a–c) Detection of Osterix reporter expression (red) in kidneys harvested from E17.5 (a), post-natal day 4 (P4) (b), and 3 week old (c) 
animals reveals the transient nature of reporter gene expression. (d, e,  e’, e’’) Imaging of Osterix reporter expression in kidney tissue 
sections at P4. (d) Scanned image of a coronal section revealing Osterix reporter expression (red) in the juxtamedullary nephrons 
(purple-hematoxylin counterstaining). (e’, e’’) Reporter expression seen at high magnification from a region of interest shown in (d) 
revealing expression in the proximal convoluted tubule and the thick descending limb of loop of Henle. (f) Analyses of endogenous 
Osterix transcription showed that only mRNA2 was transiently detected in the kidney, while expression of mRNA1 was not detected. 
 
To determine if Osterix is expressed transiently in the kidney, RT-PCR was carried out 
on transgenic positive and negative kidney samples at E17.5, P4, and 3 weeks of age 
(Fig. 9F). Interestingly, we were able to detect only one of the two isoforms in the 
kidney, mRNA2.  Also, expression of the mRNA2 isoform was transient, similar to that 
observed with our reporter gene.  For reasons that remain unclear to us, we had a very 
difficult time detecting mRNA for the Cherry reporter in the kidney at P4, near the time 
point where we are able to visualize robust fluorescent expression.   
 In this study, we have described the transgene assembly and expression of an 
Osterix-Cherry fluorescent reporter mouse model.  Characterization of reporter 
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expression suggests that the 39kb transgene largely retains many of the cis regulatory 
elements necessary for regulating Osterix gene expression in skeletal tissues from 
embryonic to adult ages. Consistent with Osterix having an essential role in osteoblast 
and chondrocyte development, Osterix reporter expression was largely restricted to both 
of these skeletal lineages.  However, we have also noted transient reporter expression in 
the kidney that was particularly strong at neonatal ages.  Given the timing of reporter 
expression in the kidney in relation to lactation, it is intriguing to speculate that perhaps 
Osterix may have a role in regulating mineral homeostasis during this period of active 
skeletal growth and development. 
 The transgenic reporter was designed to detect both transcriptional isoforms of 
Osterix.  Other groups have reported on the existence and expression of both Osterix 
isoforms, however, there is disagreement with regard to which isoform may be the 
predominant form, if any.  Milona et al. have reported that the shorter isoform (mRNA2) 
is more highly expressed in skeletal cell types [41], while Nishio et al. provided evidence 
that the longer isoform (mRNA1) predominates [2].  Our immunostaining studies, which 
have utilized an antibody that recognizes the long protein isoform of Osterix, clearly 
indicate that mRNA1 is highly expressed in osteoblasts and hypertrophic chondrocytes.  
However, analyses of isoform specific transcripts by RT-PCR on FACS isolated cell 
populations indicate that both transcriptional isoforms are likely to be expressed in a 
relatively skeletal specific manner with perhaps mRNA2 being expressed at significantly 
lower levels in non-skeletal cell types.  It remains unclear if any functional differences 
exist between either protein isoform of Osterix. 
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 One of the significant advantages of fluorescent protein reporter mice is that they 
provide investigators with the means to isolate and study intrinsically labeled cell 
populations. Work by us and others have generated a variety of different fluorescent 
reporter mice to study the osteoblast lineage [54, 64-66].  As a critical mediator of 
osteoblast commitment, Osterix has a very early and pivotal role within the osteoblast 
lineage.  Supporting this thinking, the onset of Osterix-driven Cherry expression 
appeared earlier and in a broader cell population than BSP reporter expression during 
embryonic development.  We also observed a low Osterix reporter expressing cell 
population in the bone marrow that was also BSP reporter negative, which may mark a 
very early osteoprogenitor required for supporting postnatal skeletal growth and bone 
maintenance.  Therefore, Osterix reporter mice may provide us with a means to isolate 
and study the earliest cells of the osteoblast cell lineage, which still remain poorly 
understood. 
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CHAPTER V: DEFINING THE OSTERIX-CHERRY+ 
MESENCHYMAL PROGENITOR WITHIN THE BONE 
MARROW 
ABSTRACT: 
 
In this study, we have investigated the identity and biological properties of a bone 
marrow cell population retaining low Osterix reporter expression.  Histological 
examination of reporter expression in bone tissue cross-sections revealed that bone 
marrow cells retaining low Osterix reporter expression were situated in proximity to 
endocortical bone surfaces and not uniformly distributed throughout the marrow.   
Immunostaining for the endothelial cell surface marker CD31 showed that approximately 
40% of the Osterix reporter cells associated with the vascular sinusoids, but were not 
endothelial cells.  Stromal cultures derived from Osterix-reporter mice showed that 
cherry+ cells flushed from the marrow attached to tissue culture plastic and expanded in 
culture.  Furthermore, the in vitro differentiation of day 5 sorted Osterix-reporter cells 
along the osteoblast, chondrocyte, and adipocyte cell lineages provided evidence for their 
uncommitted multipotent skeletal potential. Additionally, during osteoblast 
differentiation, Osterix reporter expression dramatically increased supporting the belief 
that low Osterix reporter expression identifies an early skeletal progenitor.  By FACS 
analysis, ~2% of the bone marrow retained cherry reporter fluorescence.  Cell surface 
profiling on the bone marrow fraction indicated that the bone marrow cell population 
retaining Osterix reporter expression was very heterogeneous in nature being 60% 
positive for CD31, 60% positive for CD11blow, and ~85-90% positive for CD45low, CD44 
and CD29.  Surprisingly, few Osterix reporter expressing bone marrow cells were 
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positive for known mesenchymal cell markers Sca1, CD105, and CD140b, with the 
exception of CD90.2. However after culturing for five days, Osterix-Cherry cells adopted 
a mesenchymal cell profile by dramatically increasing in Sca1, CD105, and CD140b, but 
retained the hematopoietic cell surface markers CD45 and CD11b. 
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INTRODUCTION: 
 
Our knowledge of bone marrow skeletal progenitor cells remains limited.  Work 
by Friedenstein provided the first evidence that skeletal progenitor cells exist in the bone 
marrow and could be extracted and expanded in culture.  This cell population was present 
at a low frequency inside the bone marrow, was adherent to tissue culture plastic, 
appeared fibroblast-like in cell morphology, retained skeletal potential and supported 
hematopoiesis [18].  Work by many other groups have substantiated Friedenstein’s work 
[19, 20, 67] and cell culture remains the easiest way to enrich and expand for these 
skeletal progenitors.   Because of their skeletal potential and accessibility through bone 
marrow aspiration, the application of these cells for therapeutic purposes has supported 
great research efforts to further define the identity and biological properties of these cells. 
The in vivo identity of the cells which establish the hematopoietic environment in 
bone marrow has not been well defined [27].  In humans, CD146+ sub-endothelial cells 
have shown to be clonogenic upon transplantation, however, a similar marker in mice has 
not been determined[26, 27].   CD146+ sub-endothelial cells reside on the vascular 
sinusoidal network within the marrow. These cells produce large quantities of 
Angiopoietin-1 and are involved in the vascular remodeling of the sinusoidal network 
[27].  Other cell types have also been shown to have a role in the hematopoietic 
microenvironment. CAR cells, which are multipotent progenitor cells, also express 
cytokines necessary for the homing and maintenance of hematopoietic stem cells in the 
bone marrow and b-cell development, including CXCL12 and Stem Cell Factor 
(SCF)[24].   Another cell type within the hematopoietic niche is the Nestin+ reticular cell 
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[29, 68], which has been shown to be multipotent and which has also been shown to 
express Osterix [69].  
Osterix is a zinc finger transcription factor, which functions as a key regulator of 
osteoblast differentiation [1, 2].  Osterix is selectively expressed in cells of the osteoblast 
lineage and has an essential function in osteoblast commitment and bone formation [1, 3].  
While it is generally accepted that Osterix is expressed in early osteogenic precursors [3, 
5-7], our understanding regarding the plasticity of these precursors for the osteoblast 
lineage relative to other cell lineages is lacking.  However, recent fate mapping studies 
using Osterix-Cre mice have provided evidence that Osterix expression occurs in early 
uncommitted skeletal progenitor cells that contribute to a variety of cell lineages inside 
the bone marrow[70].  
To better understand the early skeletal progenitor cell types retaining Osterix 
expression, we recently generated Osterix-Cherry reporter mice.  Previous studies from 
our lab and others have used fluorescent reporter mice to aid in defining cells of the 
osteoblastic lineage [71, 72].  Inside the bone marrow of this animal model is a cell 
population retaining low Osterix reporter expression (LORE) that in many ways is 
morphologically reminiscent of a reticular cell population.  Here we provide evidence 
that LORE cells represent a very early skeletal progenitor retaining multipotent skeletal 
potential.  
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RESULTS: 
LORE CELLS ARE LOCATED NEAR THE ENDOSTEAL BONE SURFACE AND ARE 
ASSOCIATED WITH VASCULAR SINUSOIDS 
 
The location of cells within the bone marrow stroma is proving to be a very 
important indicator of possible cellular function.  Past characterization of Osterix-Cherry 
reporter mice showed strong reporter expression in mature osteoblasts and 
osteocytes[53].  Relative to the robust reporter expression in mature osteoblasts and 
osteocytes, we also noted a low Osterix reporter expressing cell population present within 
the bone marrow compartment that we have referred to as LORE cells.   
 
FIGURE 10: DISTRIBUTION OF OSTERIX-CHERRY+ CELLS IN THE BONE MARROW 
(a) Cherry positive cells are seen in the  periphery of the cortical bone, when the bone is cut in cross section (blue arrows) (b) High 
Magnification of the cortical bone, showing Cherry+ cells (blue arrows) appear predominantly near the endocortical surface with few 
positive cells appearing near the central region of the marrow.  (c) Distribution pattern of Osterix-Cherry+ cells as assessed by Image J 
(representative graph); much of the Cherry+ cells appear adjacent to, or within the first 20% of the marrow radially, near the 
endocortical surface.  
To better elucidate the location of these cells within the marrow, we sectioned 
long bones derived from Osterix-Cherry reporter mice in a longitudinal plane and in 
cross-section.  As seen in the cross-section taken from the mid-diaphysis of a three week 
old femur, these cells seem to congregate near the endocortical surface (Fig 10 A, B high 
mag, blue arrows).   There are very few LORE cells near the center of the marrow.  The 
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LORE cells appear to be within the first few cell layers, under 100µm from the 
endocortical surface. This can also be seen if the bone is cut in a longitudinal section 
close to the endocortical surface (data not shown). Multiple sections were cut in the 
transverse plane and were analyzed to determine the distribution of the Osterix-Cherry+ 
cell in the marrow.  The analysis showed that all of the Osterix-Cherry+ cells were 
located in a ring which included about 20% of the radius of the marrow space, near the 
endocortical surface (Fig 10C).       
Many LORE cells morphologically appeared similar to bone marrow reticular 
cells, containing thin dendritic like processes.  Along these lines, sub-endothelial 
perivascular stromal cells, which associate with the bone marrow vascular sinusoids have 
been shown to display skeletal potential  [73].  Therefore, we carried out CD31 
immunostaining to visualize the location of bone marrow endothelial cells to Osterix-
Cherry+ cells.  Immunostaining showed that a subpopulation of LORE cells were 
associated with the vascular sinusoidal network (Fig 11 A-C).      
Based on our analysis of our immunostaining (and subsequent FACS) we knew 
that not all of the CD31+ cells were Cherry+, nor were all Cherry+ cells positive for 
CD31.   However, we felt that it was likely that Osterix-Cherry cells were associating 
with CD31+ endothelial cells(Fig 11).   
We also looked at Alkaline Phosphatase (ALP) staining using a set of reagents 
that was spectrally distinct from our Cherry reporter.  ALP staining marked many of the 
Osterix-Cherry+ dendritic cells, especially those close to the endocortical surface (Fig 11 
D-F).   
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EXAMINATION OF OSTERIX REPORTER EXPRESSION IN BONE MARROW 
STROMAL CULTURES 
 
Given the detection of LORE cells inside the bone marrow, stromal cultures were 
carried out to determine if and how well LORE cells contributed to the overall adherent 
stromal cell population.  By FACS roughly 1-2% of the total cell population from the 
flushed bone marrow retained Osterix reporter expression (Fig 12J).  Osterix reporter 
labeled cells were imaged at progressive stages of culture during growth and osteogenic 
differentiation.  In the heterogeneous environment of the stromal culture, we noted 24 
hours after plating that a small subpopulation of fluorescent cells attached to tissue 
culture plastic, established a mesenchymal cell morphology, and were organized in small 
colonies of cells (Fig 12 A).  For reasons that are not clear, some cell colonies persisted 
FIGURE 11: CD31 IMMUNOSTAINING AND ALP STAINING IN 
THE MARROW    
(a)  Section of the bone  marrow of a 3 week  old mouse, showing 
GFP reporter expression for  Osterix Cherry  (b) Same section of 
the marrow, showing immunostaining for CD31, marking the 
sinusoids within the marry. (c)  Osterix-Cherry and CD31 staining 
overlay, showing the association of the Osterix cherry positive cells 
(Red) with the CD31+ (Green) sinusoidal network.  Approximately 
40% of the Cherry+ cells associate with CD31+ vascular sinusoids. 
(d) Section of the bone marrow from a 7 week old mouse, showing 
Osterix Chery expression. (e) ALP fast blue staining for Alkaline 
phosphatase showing the dendritic nature of ALP positive cells (f) 
Osterix-Cherry and ALP staining overlay, showing the ALP staining 
(Green) surrounding the Osterix-Cherry positive cells (Red)  near 
the endocortical surface.   Scale bars are all 20um. 
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in culture, while others did not.  At days 3 and 4 of culture, reporter gene intensity 
decreased (Fig 12 A-D).  However, after the addition of osteogenic inducing agents at 
day 7, the intensity of Osterix reporter expression noticeably increased (Fig 12 compare E 
to F).  By day 14 of culture, strong Osterix reporter expression can be detected in 
colonies defining putative regions of mature osteoblast differentiation (Fig 12F).   By day 
21, Osterix reporter expression was even brighter and correlated with areas of 
mineralization detected by von Kossa (Fig 12 compare G to H).
 
FIGURE 12: OSTERIX-CHERRY EXPRESSION CHANGES DURING DIFFERENTIATION 
(a-d) Early culture progression from 24 hours after plating (Day 1) to Day 4. Osterix Cherry expression gets more diffuse and weaker 
at the early stages of culture, though the number of cells which are Osterix-Cherry+ continues to increase.  The weakening trend 
reverses at Day 5, at which point the cells increase in intensity through the culture period (e-i) Established culture progression up 
through Day 21 of osteogenic differentiation. Osterix Cherry expression continues to increase as the culture progresses (e-g) Days 7, 
14 and 21 of culture showing weaker Osterix-Cherry colonies spread throughout the plate, which increase at Day 14 and further 
increase at Day 21.  Exposure times are consistent (h) Von Kossa staining of a Day 21 culture, showing that areas of mineralization 
correlate with areas of strongest Osterix-Cherry expression  (i) FACS analysis shows the percentage of stromal cells isolated from the 
marrow are Cherry +  up through Day 21 of the culture period (j) FACS analysis showing the percentage of Osterix-Cherry+ cells in 
the flushed bone marrow 
We also quantified the percentage of cells retaining cherry fluorescence protein 
by FACS.  At day 0, approximately 2% of the cells isolated from the bone marrow are 
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Cherry+.  This increased substantially by day 4, with approximately 30% of the cells 
becoming Cherry+ (data not shown).  By day 7, close to 50% of these cells are positive 
for Osterix-Cherry and by day 21, when the culture is actively mineralizing, 
approximately 80% of the total cells in the culture are Cherry+ (Fig 12I).  
LORE CELLS RETAIN MULTIPOTENT SKELETAL POTENTIAL 
 
To further characterize the stromal cell population retaining Osterix reporter 
expression, we carried out in vitro differentiation studies.   For these studies, the Osterix 
reporter labeled cell population was FACS sorted from day 5 stromal cultures, replated in 
culture, and differentiated along the osteoblast, adipocyte, and chondrocyte cell lineages.  
In vitro differentiation was assessed by using histological staining to detect mineral 
deposition (Fig. 13C), von Kossa), lipid vesicle formation (Fig. 13G, Oil Red-O), and 
proteoglycan production (Fig.13K, Alcian blue).  Gene expression analyses were also 
carried out on days 0, 5 and 8 (osteoblast and adipocyte cultures) or days 0, 7 and 14 
(chondrocyte cultures) to assess differentiation (Fig.13 D, H, L).  
Not surprisingly, sorted Osterix reporter labeled cells efficiently differentiated 
into bone.  During osteoblast differentiation, Osterix reporter expression substantially 
increased (Fig.13A and previously shown in Fig12), mineralization was visible under 
DIC optics (Fig 13B) and by von Kossa staining (Fig 13C).  During osteoblast 
differentiation, mRNA levels of Bone Sialoprotein (BSP), Osteocalcin, and Dentin 
Matrix Protein (DMP1) also dramatically increased.  
 Sorted Osterix labeled cells also retained the capacity to differentiate into 
adipocytes. During adipocyte differentiation, reporter expression decreased substantially 
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in cells that developed large lipid vesicles, while mesenchymal cells located around 
forming adipocytes maintained Osterix reporter expression.  Changes in cell morphology 
and large lipid vesicles were observed under DIC optics (Fig 13F) and Oil Red O staining 
for lipids was also detected throughout the culture (Fig 13G).  Gene expression analyses 
also showed that the adipocyte gene markers Adiponectin, Adipsin and Perilipin were all 
substantially up-regulated during differentiation (Fig 13H).   
FIGURE 13:  MULTIPOTENCY OF THE 
OSTERIX-CHERRY+ POPULATION BY 
HISTOLOGY AND GENE EXPRESSION 
Sorted cell populations were plated as a 
micromass and induced to differentiate into bone 
(a-d), fat (e-h) and cartilage (i-l).  The 
morphological changes can be visualized 
through fluorescence microscopy (a, e, i) and 
DIC optics (b, f, j).  Histological staining was 
performed for mineralized matrix (c), fat 
deposition (g) and proteoglycans (k).   Cells  
were collected from these micromass cultures at 
early, middle and late time points and various 
bone (d),  fat (h) and cartilage (l) genes were 
characterize by qPCR.  Cultures derived from 
Osterix-Cherry positive cells show a robust 
increase in lineage specific genes 
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Sorted Osterix-Cherry+ cells also retained the ability to differentiate into 
chondrocytes. During chondrocyte differentiation, cells maintained their Osterix reporter 
expression, but the intensity of the reporter was less compared to levels of expression 
during osteoblast differentiation (Fig 13I).  Under DIC optics, mesenchymal cells formed 
condensations within the micromass (Fig 13J) and proteoglycan expression could be 
detected by staining with Alcian Blue (Fig 13K).  Gene expression analyses of 
chondrocyte formation showed up-regulation of Sox9, Collagen type 2 alpha 1, and 
Collagen type 10 alpha 1  (Fig 13L).   
Taken together, these in vitro studies provide evidence that Osterix reporter 
labeled cells from the bone marrow contribute to a stromal cell population that retains 
multipotent skeletal potential.   
CELL SURFACE PROFILING AND GENE EXPRESSION FROM LORE CELLS 
REVEALS THEIR HETEROGENEITY 
 
To further understand the identity and homogeneity of the bone marrow cell 
population retaining Osterix reporter expression, cell surface profiling was carried out on 
cells directly flushed from the bone marrow and after 5 days in culture. As previously 
mentioned, between 1-2% of the total bone marrow fraction retained Osterix reporter 
expression (Fig 12 J), though this can be divided into two parts based on the intensity of 
the cherry expression (Fig 14, Gating Control).  A variety of cell surface markers were 
used including hematopoietic (CD45 and CD11b), endothelial (CD31), and mesenchymal 
(CD44, Sca1, CD29, CD105, CD90.2 and CD140b). 
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When profiled directly from the bone marrow, three populations of cells were 
elucidated: a cherry negative fraction (blue), a cherry low population (green) and a cherry 
high population (red).  All cell populations have high levels of CD45 (~75-95%), CD44 
(>85%) and C29 (>85%).  Cherry positive cells from both groups show higher levels of 
CD11b (~60%) than the negative fraction (~30%).  The cherry high population has 
significantly higher levels of CD31 (~85%) than either the negative (~35%) or the low 
(~50%), likely due to the association of those cells with the vascular sinusoidal network. 
All populations have low levels of Sca1 (<10%), CD105 (<10%) and CD140b (<5%).  Of 
interest is CD90, which is considered to be an MSC marker; approximately 50% of the 
cherry positive cells were positive for CD90, whereas less than 5% of the cherry low or 
negative cells were positive for CD90 (Fig 14).    
After culturing for 5 days, the cell surface profile of the Osterix-Cherry 
population significantly changed (Fig 15).  Minimal CD31 expression was detected and 
mesenchymal markers Sca1, CD105, and CD140b all markedly increased in the cherry 
positive population.  Interestingly, hematopoietic cell surface markers CD45 and CD11b 
still persisted, in many cases at higher levels than initially detected directly from the 
marrow.   CD105 and CD140b are detected at very low levels in the negative; however 
these markers are now expressed in 40% and 70% of the cherry positive cells, 
respectively. CD90 expression in the cherry positive population is lost in culture. 
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FIGURE 14 : CELL SURFACE PROFILING FROM THE BONE MARROW 
Cells flushed from the marrow of 3-week old mice (n=3) were gated based on cherry expression into 3 groups: negative (Blue), cherry 
low (Green) and cherry high(Red).  Each group was analyzed for a variety of cell surface markers including CD45, CD31, CD11b, 
CD44, CD29, Sca1, CD105, CD140b and CD90.  The cell surface marker+ populations graph shows a typical plot, in this case, CD45, 
indicating where each population falls per quadrant.  Populations were analyzed and the percentage of cells in each group which was 
positive for the marker was graphed.   
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FIGURE 15 : CELL SURFACE PROFILE OF CULTURED BONE MARROW CELLS 
Cells flushed from the marrow of 3-week old mice (n=3) were individually cultured for 5 days, then enzymatically digested and 
subjected to FACS sorting.  Cells were gated based on cherry expression into 2 groups: negative (blue) and cherry high (red).  Each 
group was analyzed for a variety of cell surface markers including CD45, CD31, CD11b, CD44, CD29, Sca1, CD105, CD140b and 
CD90.  The cell surface marker+ populations graph shows a typical plot, in this case, CD45, indicating where each population falls per 
quadrant.  Populations were analyzed and the percentage of cells in each group which was positive for the marker was graphed. 
Culturing the bone marrow drastically changes the cell surface profile.  The most 
dramatic change is the loss of the lowest expressing cherry positive population.  The 
expression of cherry in the cultured cells is much more uniform than that seen directly 
from the marrow.  After culture, cherry positive cells lose CD90 and CD31, but gain 
mesenchymal markers like Sca1, CD140b and CD105.  Clearly, the environmental 
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differences between the bone marrow and those seen during cell culture result in notable 
changes in the cell surface 
phenotype.  
To try to further 
determine the identity of 
the Osterix-Cherry positive 
cell, we also examined the 
expression of Stem Cell 
Factor (SCF) and CXCL12 
in the our Osterix-Cherry 
sorted fraction directly from 
the bone marrow, as these markers have been shown to be upregulated in the sub-
endothelial cells in the niche that are multipotent. Osterix was increased about 30-40 fold 
in the cherry positive population compared to the cherry negative population (confirming 
our sort efficiency and that our reporter model is accurately marking cells expressing 
Osterix (data not shown)).  CxCl12 and Stem Cell Factor were both modestly upregulated 
in the sorted cherry positive population compared to the cherry negative (Fig 16).  
FIGURE 16: UPREGULATION OF CXCL12 AND STEM CELL FACTOR IN SORTED 
CHERRY POSITIVE CELLS FROM THE MARROW 
Cells directly from the marrow were sorted, RNA was extracted and cDNA was made.  qPCR 
was performed for CXCL12 and Stem Cell Factor.  There is modest upregulation of both in the 
cherry positive population as compared to the cherry negative. 
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DISCUSSION: 
 
In this study, we have investigated a novel bone marrow cell population retaining 
low Osterix reporter expression (LORE).  Given the functional role of Osterix and the 
location of LORE cells in proximity to endocortical bone surfaces, a reasonable 
assumption is that LORE cells may represent an early osteoprogenitor cell type.  In 
agreement with this thinking, staining for alkaline phosphatase, an early gene marker of 
osteogenesis co-localized with many LORE cells.  However, further characterization of 
the LORE cell population implicated that at least a subpopulation may be comparable to 
bone marrow mesenchymal stem cells (BMSCs) or the multipotent perivascular stromal 
cell.  First, immunostaining in tissue section showed that ~43% of LORE cells associated 
with the vascular sinusoids similar to other multipotent perivascular stromal cell types.  
Second, gene expression levels for perivascular gene markers SCF and Cxcl12 were all 
up-regulated in the Osterix-Cherry+ cell fraction compared to the negative cell fraction.  
Third, a subpopulation of Osterix-Cherry+ cells were adherent to tissue culture plastic 
and grew in colonies as one would expect from BMSCs [19, 20].  Finally, in vitro 
differentiation of sorted Osterix-Cherry cells provided evidence for their skeletal 
multipotency. 
At the same time, cell surface profiling indicates that the LORE cell population is 
likely to be heterogeneous.  Osterix reporter labeling seems to favor higher expression of 
CD11b and cells which express high levels of cherry also express high levels of CD90.   
As these cells are cultured, their cell surface profile changes.  The Cherry+ 
population loses expression of CD31, and gains expression of more mesenchymal 
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markers, like CD44, CD29, Sca1, CD105 and CD140b [67, 74], with culture. 
Traditionally, CD45 and CD11b are not considered to be expressed in a mesenchymal 
population; however, our data shows that both markers remain high after 5 days in 
culture.  We are currently studying the CD45+ and the CD11b+ population to try to 
determine why these markers seem to be maintained in our population.  Ooi, et al. 
suggested that BMSCs originally start out as CD45+ and then lose that expression over 
time. [75, 76] This is similar to what we are seeing with our Cherry+ cell population.   
The bone marrow is a very heterogeneous environment.  Teasing out various cell 
populations, even with the tools available to us, is difficult.  In this study, we have 
identified a small population expressing Osterix in the bone marrow that associates with 
the vascular sinusoids and is ALP+.   This Osterix-Cherry+ cell adheres to tissue culture 
plastic and is multipotent.  However, there are subpopulations within this small 
population which make further characterization difficult.   Multiple cell types reside on or 
near the vascular sinusoidal network.  These cells often display similar properties to our 
Osterix-Cherry+ population.  The Osterix-Cherry reporter allows us to pull apart some of 
these populations based on intensity and proximity to the endocortical surface, but we 
have yet to fully characterize all of the subpopulations that are reporter positive that we 
see within the marrow. 
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CHAPTER VI: OVERVIEW AND FUTURE DIRECTIONS: 
 
Fluorescent reporter animal models are valuable tools to investigate biological 
processes.  To learn more about osteoblast biology, in this thesis, we have presented work 
on the generation and characterization of Osterix-Cherry reporter mice.  While the utility 
of this animal model may have broad applications within the field of skeletal research, 
our studies have been primarily focused in two areas. First, characterizing reporter 
expression in correlation to the endogenous Osterix gene expression and secondly, 
scrutinizing the identity of cell types retaining reporter expression with a particular 
interest on bone marrow skeletal progenitor cells.  Our Osterix reporter mice have 
allowed us to tease out some of the intricacies of the Osterix gene and its regulation.  
 
OSTERIX EXPRESSION IS NOT EXCLUSIVE TO THE OSTEOBLAST LINEAGE 
The importance of Osterix for osteoblast differentiation is well established [1, 7, 
44, 63, 77, 78], thus we anticipated reporter expression would be largely exclusive to 
cells of the osteoblast lineage.  In agreement with previous studies, Osterix reporter 
expression was highly and selectively expressed in cells of the osteoblast lineage with 
strong reporter expression being present in mature osteoblasts and osteocytes.  However, 
our studies also revealed that Osterix is also expressed in maturing chondrocytes.  
Interestingly, Osterix reporter expression progressively increased in growth plate 
chondrocytes with age.  Consistent with these observations, recent work has validated an 
essential role for Osterix in chondrocyte differentiation [62].   
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In addition to the growth plate, during early postnatal life, we also detected very 
robust, but transient Osterix reporter expression in the collecting ducts of the kidneys.  
The timing of expression in newborn animals seemed to coincide with the onset of 
suckling.  Thus, while a role for Osterix in the kidney remains to be determined, we 
speculate that Osterix may be involved in the regulation of calcium-phosphate 
reabsorption during this very active phase of skeletal growth.   
 
LOW OSTERIX REPORTER EXPRESSION MARKS A BONE MARROW CELL 
POPULATION 
 
While Osterix reporter expression was robustly detected in mature osteoblasts and 
osteocytes, we also noted cells present within the bone marrow that retained low levels of 
reporter expression.  Careful examination of Osterix reporter expression by sectioning 
bone tissue in cross-section revealed that low Osterix reporter cells were located in 
proximity to endocortical bone surfaces.  Compared to previously generated osteoblast 
reporter mouse models, including Bone Sialoprotein –Topaz and Collagen 1a1 3.6–Cyan, 
which had little to no expression in any bone marrow cell population, the detection of 
Osterix reporter expression in a bone marrow cell population was novel.   
Given the early role for Osterix in osteoblast differentiation and the proximity of 
these cells adjacent to the bone surface, we hypothesized that this cell population was an 
early osteoprogenitor cell population.    One of the benefits we found with this mouse is 
that we have a fluorescent population within the marrow that can be FACS isolated, 
allowing for careful analysis of this specific stromal  population, even though it makes up 
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a very small percentage (1-3%) of the marrow.  Thus, our work from that point forward 
sought to characterize this cell population. 
OSTERIX REPORTER EXPRESSION STROMAL CELLS DISPLAY 
MESENCHYMAL MULTIPOTENCY 
 
Stromal cultures derived from Osterix reporter mice revealed that cells taken from 
the bone marrow containing Osterix reporter expression directly contributed to an 
adherent cell population.  This was recently confirmed by FACS isolation of Osterix 
reporter positive cells directly from the bone marrow and their contribution to colony 
formation in co-cultures.  Interestingly, in vitro differentiation studies implicate that the 
Osterix reporter expressing cell population does retain multipotent properties, being able 
to differentiate into osteoblasts, adipocytes, and chondrocytes, in vitro.  These findings 
were somewhat surprising because it is well established that functionally Osterix has an 
important role in osteoblast commitment [7, 11, 41, 63].  However, consistent with our 
studies, recent fate mapping studies demonstrated how embryonic progenitors labeled by 
Osterix-Cre and Osterix-CreERT2 mice traced into a variety of cell types within the bone 
marrow including adipocyte, perineural, vascular smooth muscle, and stromal in addition 
to the osteoblast lineage[70].  Thus, low and early Osterix reporter expression potentially 
identifies a cell population of osteoprogenitor cells that are not fully committed to the 
osteoblast lineage and can contribute to other cell lineages.   
Our studies also suggest that the post-transcriptional regulation of Osterix is likely 
to be critically important for osteoblast differentiation.   In this regard, some recent 
studies have started to elucidate at least some of the post-transcriptional mechanisms 
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which regulate Osterix function[77].  BMP2/ Smad signaling can act indirectly on 
Osterix through Runx2 and Dlx5. Both of these pathways, along with the activation of the 
MAPK signaling cascade will enhance the phosphorylation and thus enhance the 
expression of Osterix, as does Igf1 and the Unfolded Protein Response[79-81].  TNFa 
and p53 can repress the expression of Osterix by preventing its phosphorylation [3, 82].  
Also, various other mechanisms, like DNA methylation and microRNAs allow for 
epigenetic control of Osterix expression [83, 84].  Further studies have shown the NO66 
represses phosphorylated Osterix activity and NFATc enhances the activity of 
phosphorylated Osterix [85-87].  
 
CLINICAL RELEVANCE OF OSTERIX: 
  Osterix has recently been implicated in a variety of skeletal diseases.  Originally, 
based on mouse studies, deficiencies in Osterix were thought to be lethal in humans as 
well, but some recent studies  by Lapunzina et al have identified a Single Nucleotide 
Polymorphism (SNP)  in an Egyptian Osteogenesis Imperfecta  (OI) patient, producing a 
truncated Osterix protein[88].   Osteogenesis Imperfecta has long been associated with 
mutations in Collagen, not Osterix, so this mutation shows another potential causative 
agent for OI.  Genome Wide Association Studies (GWAS) have shown that SNPs in 
Osterix are strongly correlated with adult lumbar spine BMD and increased BMD in 
females with childhood obesity [89, 90].    Taken together, these studies show a clear 
significance for Osterix in bone health[77].  
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  In order to study how Osterix is involved in bone disease, we could modulate 
various factors: one could examine how the disease process or a potential treatment 
effects cells of all stages of the osteogenic lineage based on our Cherry reporter.   We 
have the potential to be able to regulate Osterix in vivo and in vitro using small 
molecules– looking at how agonists and antagonists of certain pathways change the 
expression of the reporter. 
 
AN UNEXPECTED CELL SURFACE PROFILE FOR OSTERIX REPORTER 
EXPRESSING BONE MARROW CELLS 
To more clearly define the bone marrow cell population retaining low Osterix 
reporter expression, we carried out cell surface profiling directly from the bone marrow 
and from day 5 stromal cultures.  While the cell surface profile of osteoprogenitor cells 
has not been well defined, because of their mesenchymal-like multipotency, we 
speculated they might have a cell surface profile similar to previously reported bone 
marrow stromal cell populations.  Surprisingly, characterization directly from the bone 
marrow revealed a more complex profile that included cell surface markers commonly 
associated with the hematopoietic and endothelial cell lineages including CD45+, 
CD11b+, and CD31+.  The potential significance of hematopoietic cell marker 
expression on the Osterix reporter expressing cell population remains unclear.  Perhaps it 
is a signature correlated with cell-cell communication occurring in the bone marrow.  
Additionally, three known mesenchymal cell surface markers (CD44, CD29, and CD90) 
were up-regulated in the Osterix reporter population while other mesenchymal markers 
like Sca1 and CD105 and CD140b were scarcely present.  
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Interestingly, transition into a cell culture environment resulted in a significant 
alteration in cell surface profile more consistent with what has been previously reported 
for mesenchymal stem cells.  After 5 days in culture, Osterix reporter cells were Sca1+, 
CD105+ and CD140b+ in addition to having very high levels of CD44 and CD29.  
Surprisingly, they also retained CD45+ and CD11b+ surface markers; however the 
staining intensity for these hematopoietic markers was lower than that of the negative 
fraction.   The alteration in cell surface profiling from the bone marrow environment to 
the tissue culture environment may reflect a combination of possibilities. First, different 
environments resulted in substantial changes in cell profiles.  The in vivo bone marrow 
environment is substantially more complex and likely to have broader diversity, whereas 
the tissue culture environment is more uniform, thus similar cells will have a common 
response and possibly alter their cell surface phenotype in the same manner.  
Additionally, during the transition from the bone marrow environment to the cell culture 
environment, a substantial selection process takes place resulting in the presence and 
expansion of certain cell types over others. 
The expression of cell surface markers more consistent with the myeloid lineage 
(CD11b, CD115, and F4/80) on Osterix reporter cells is currently an area we are actively 
investigating.   It remains unclear if these are macrophages that have engulfed dead 
osteoblasts and have acquired cherry fluorescence through phagocytosis or if the gene 
expression of these cell surface markers remains promiscuous and crosses over into the 
osteoblast lineage.    
A second possibility is that a subpopulation of Osterix reporter expressing cells 
are fibrocytes.  Fibrocytes are mesenchymal progenitors that exhibit characteristics of 
 
 
86 
 
hematopoietic stem cells, monocytes and fibroblasts [91].  These cells have a very similar 
cell surface marker profile to what we are seeing in our reporter positive cells, especially 
from the bone marrow.  Based on the markers we tested, both our reporter positive cells 
and fibrocytes are CD45+, CD11b+ and CD29+ [91, 92].   Future experiments will try to 
tease out the identity of the Osterix reporter expressing cells in the marrow.  
 
CELLULAR HETEROGENEITY AND THE BIOLOGICAL COMPLEXITY OF THE 
BONE MARROW ENVIRONMENT 
 
The bone marrow is a complex and heterogeneous environment. There are 
multiple cell types and niches within the marrow itself which each have their own unique 
biology and characteristics.  Studies from our lab have shown that most cell types which 
contribute to the structure of the stroma, maintain their niche and location within the 
marrow[70].  Clearly, there is evidence that given the functional role of Osterix and the 
location of Osterix–Cherry+ cells in proximity to endocortical bone surfaces, a 
reasonable assumption is that these cells may represent an early osteoprogenitor cell type, 
but it is also possible that progenitor cells may be reacting to signals within their local 
environment such that cells which are closer to the endosteal surface take on different 
characteristics then when they are in the center of the marrow.   Our Osterix-Cherry+ 
cells are likely representing at least two subpopulations, based on reporter intensity, cell 
surface profiling, immunostaining results and proximity to the bone surface.  Further 
studies will be necessary to elucidate the identity of each subpopulation of Osterix-
Cherry+ cells and to characterize their distinct roles in the marrow environment and why 
Osterix expression is needed for these cell types.  
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